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Summary 
Over the past decade, genome-wide studies have made it clear that the 
mammalian genome is pervasively transcribed and this led to the identification of 
non-protein coding RNA molecules. Only 2% of the mammalian genome 
accounts for protein-coding sequences, so that the majority is transcribed as 
noncoding RNA (ncRNA). ncRNAs appear to be highly conserved and are 
considered to be an important component for genetic regulation via epigenetic 
mechanisms. The regulatory ncRNAs can be classified into long non-coding 
RNAs (lncRNAs) and microRNAs (miRNAs).  
miRNAs increasingly recognized to play a pivotal role in both 
physiological and pathological conditions, including mammalian development, 
cardiovascular, neurodegenerative and metabolic diseases, cancer and immune 
disorders. Despite the evidence for the importance of miRNAs in immune cell 
function and development, very limited information is available regarding how 
miRNAs regulate neutrophils development, lifespan and functions. Based on these 
premises, the purpose of this study was to provide a comprehensive analysis of 
microRNAs expression profile and to identify their role in primary human 
neutrophils under resting and stimulatory conditions. To achieve this goal we 
performed whole transcriptome analysis and characterized the pri-miRNome of 
resting and LPS-stimulated neutrophils. In parallel, the same analysis was 
performed also on autologous monocytes, in order to get insight into cell-specific 
miRNA profile.  
The results of this study showed that TLR4 engagement triggers the 
transcription of 37 pri-miRNAs. Additionally, comparison of LPS-induced pri-
miRNA expression profile of neutrophils with that of autologous monocytes 
identified subsets of pri-miRNAs modulated by LPS in both cell type in a cell-
specific manner. LPS induced the expression of twelve pri-miRNAs in 
neutrophils, among which we further validated the expression of the mature forms 
of the miR23a cluster members. The members of this cluster have been described 
to play important roles in various biological and pathological processes, but their 
role has never been previously identified in resting and/or activated neutrophils. 
Upon LPS stimulation neutrophils upregulate only the mature forms of miR-23a-
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5p and miR-27a-5p. In silico target prediction indicated Fas, a death receptor 
mediating cell apoptosis, among the miR-23a predicted target genes. Herein we 
provide several experimental proofs demonstrating that LPS reduces neutrophil 
Fas-induced apoptosis in a miR-23a-dependent manner. In fact, and consistent 
with a prolonged neutrophils’ half-life, in the presence of LPS a parallel 
upregulation of miR-23a and down-regulation of Fas membrane protein, but not 
Fas mRNA, expression was detected, suggesting involvement of a post-
transcriptional regulation for Fas. Both Fas mRNA and miR-23a were detected in 
Ago immunoprecipitates only in LPS-stimulated neutrophils, thus indicating that 
LPS promotes miR-mediated post-transcriptional silencing of FAS. Finally, 
neutrophils overexpressing miR-23a reduced Fas membrane receptor. Taken 
together these data demonstrated that LPS stimulation affects neutrophil apoptosis 
via increasing miR-23a, which in return decreases the Fas expression on 
neutrophil surface.   
Collectively, we have described the expression profile of pri-miRNAs in 
resting and LPS-activated human neutrophils and their autologous monocytes, 
resulting in identification of cell type specific pri-miRNAs. The information from 
this whole transcriptome study led us to link the LPS to neutrophil apoptosis via 
miRNA modulation. Our data could be substantially used for further investigation 
on the role of miRNAs in neutrophils biology. 
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1. Introduction 
Inflammation is the process of recruitment and activation of cells of the 
innate and acquired immune system in response to infection, trauma or injury [1]. 
The normal course of inflammation is directed toward removal of the inducing 
agent and repair of damage, followed by elimination of the inflammatory cells [2]. 
Since this process is critical to host defence and homeostasis, inflammation must 
be extremely tightly regulated. Indeed, it is the classical two-edge sword: too 
little, and one is overwhelmed by infection or injury; too much, and the disease 
symptoms themselves become overwhelming [3]. The inflammatory process 
consists of coordinated, sequential and self-limiting release of different mediators 
that orchestrate and control the chronological phases of leukocytes recruitment, 
activation and clearance [2]. Polymorphonuclear neutrophils (PMN) represent the 
first and the most numerous type of leukocyte recruited at the inflammatory site in 
the initial phases of acute inflammation, while monocytes dominate the chronic 
phase and set the stage for the specific immune response. These cell types play a 
significant role in the inflammatory reaction not only by virtue of their ability to 
kill pathogens, but also for their ability to produce both pro- and anti-
inflammatory cytokines and chemokines [3, 4]. Neutrophils function as an 
essential first line of defense against invading pathogens, such as bacteria, fungi 
and viruses. They utilize several effector mechanisms to defeat pathogens, 
including phagocytosis, discharge of constitutively stored antimicrobial enzymes 
or toxic factors, generation of massive amounts of reactive oxygen species (ROS) 
and active release of nuclear material (DNA, histones and other chromatin 
proteins) aggregating into neutrophil extracellular traps (NETs)  [5]. 
Accumulating in vitro and in vivo evidence indicate that, in addition to direct 
antimicrobial activities, neutrophils play critical functions in the regulation of 
innate and adaptive immune responses. These activities are exerted largely via the 
release of cytokines and preformed or newly synthesized mediators in response to 
pattern recognition receptors (PRR)-mediated sensing of danger signals generated 
by invading pathogens or tissue damage [6].  
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Some of the activities described above for neutrophils are broadly shared 
by monocytes. However, due to their underlying molecular peculiarities these two 
cell types also show functional differences. Both at steady-state and after 
activation, neutrophils display a unique transcriptional profile and a specific 
pattern of cytokine production as compared to monocytes stimulated under the 
same conditions [7-9]. These occurrences likely reflect fundamental differences in 
neutrophil and monocyte ontogeny, as well as in transcriptional and epigenomic 
regulation.  
As described above, neutrophils and monocytes exert both over-lapping 
and cell-specific functions in innate immunity. Activation of the same PRR in 
autologous neutrophils and monocytes indeed triggers distinct gene expression 
programs [9-11], reflecting cell type-specific mechanisms of transcriptional and 
post-transcriptional regulation of gene expression. In this context, cytokines 
expressed by neutrophils and monocytes represent crucial mediators for the 
immune functions of these cells and are the focus of extensive investigations at 
molecular level. However, various studies have emphasized that, at least in vitro, 
the extent of cytokine production by human neutrophils is generally lower than 
monocytes or lymphocytes on a per cell basis [12]. Nonetheless, the contribution 
of neutrophil-derived cytokines in inflamed tissues is certainly fundamental, in 
view of the fact that neutrophils often outnumber mononuclear leukocytes by one 
to two orders of magnitude [13]. Furthermore, neutrophils and monocytes 
activated with the same microbial agonists produce qualitatively different 
cytokines, exemplified by IFNβ, IL-10 and IL-6.  
Differential induction of some genes in neutrophils and monocytes can be 
explained by the activation of cell type-specific signaling pathways in response to 
the same agonist. Indeed, upon recognition of LPS, Toll-like receptor (TLR) 4 and 
the co-receptors CD14 and MD-2 trigger a coordinated set of biochemical events 
that rely on the adaptor proteins MyD88 and TRIF [14]. MyD88 signaling from 
the plasma membrane mediates an early wave of NF-kB and mitogen-activated 
protein kinase (MAPK) activation, whereas trafficking of TLR4 to endosomes is 
required for TRIF signaling, in turn leading to activation of interferon regulatory 
factor3 (IRF3) and NF-kB. The combined activity of all these transcription factors 
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(TFs) controls transcriptional induction of IFN, which in an autocrine manner 
triggers the expression of a large set of interferon-stimulated genes (ISG) with 
anti-viral and immunomodulatory functions. For reasons that still need to be 
clarified at molecular level, human neutrophils incubated with LPS fail to activate 
the TRIF-dependent pathway and consequently do not express IFN-β mRNA and 
other ISGs [15]. On the other hand, the MyD88-dependent pathway seems to be 
fully functional in human neutrophils [16]. 
Other than activation of cell type-specific signaling pathways, 
accumulating evidence indicates that differential chromatin organization in 
neutrophils and monocytes may represent a critical factor to explain 
transcriptional differences observed in the two cell types. Indeed, pro-
inflammatory transcription factors activated by external stimuli largely act within 
a pre-established regulatory landscape, thus impacting on the transcriptional 
output of TLR stimulation [17]. In this context, for instance, recent data provide a 
mechanistic support to the inability of highly purified human neutrophils to 
produce IL-10 [10]. A comparative analysis of the histone modifications at the 
IL10 locus of freshly isolated human neutrophils and autologous monocytes 
revealed that histone modifications associated with transcriptionally permissive 
chromatin, (namely H3K4me3, H3K27Ac/H4Ac and H3K4me1), are detectable in 
monocytes, but not in neutrophils, already at steady-state. Moreover, upon 
stimulation with TLR ligands or acute-phase protein serum amyloid A (SAA), 
H3K4me3 and H3K27Ac marks were further increased in monocytes, but not in 
neutrophils [18].  
Besides chromatin organization, other critical transcriptional regulators are 
involved in gene expression regulation likely include noncoding RNAs, such as 
long noncoding RNA (lncRNA) and microRNAs (miRNAs). In this context, our 
understanding of the molecular bases of gene expression in neutrophils is still 
poor, possibly due to the objective difficulties in isolating these cells at high 
purity [13] and manipulate them in culture, issues that are particularly critical in 
human samples. 
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MicroRNAs 
miRNAs constitute a class of highly conserved endogenous small non-
coding RNAs of approximately 22 nucleotides in length that can regulate gene 
expression post-transcriptionally by affecting the half-life and translation of target 
mRNAs [19, 20]. The discovery of these non-coding RNAs as regulators of gene 
activity began almost 16 years ago with the identification in the nematode worm 
C. elegans of lin-4, a gene that encodes short RNA transcripts able to inhibit the 
translation of the lin-14 messenger RNA by binding to its 3’ untranslated region 
[21]. Since then, a large number of endogenous mature small RNAs were 
identified. To date, 2588 human miRNAs have been annotated and catalogued in 
web-based miRNA database known as miRBase (http://www.mirbase.org; 
Release 21), and many of them have been implicated in almost all the cellular 
systems and biological processes [20, 22, 23].  
MicroRNAs Biogenesis 
Human miRNAs are processed from primary transcripts which may be 
originated from introns, intergenic regions or non-coding RNAs. Mature miRNAs 
are produced from long primary transcripts that contain the pre-miRNA, through a 
series of endonucleolytic maturation steps (Figure 1). Most primary miRNA 
transcripts (pri-miRNAs) are transcribed by RNA polymerase II, have 5’ caps and 
3’ poly(A) tails, and are hundreds of nucleotides long. The pri-miRNAs are 
processed in the nucleus by the RNase III enzyme, Drosha, and the double 
stranded-RNA-binding protein, DGCR8 (DiGeorge syndrome critical region gene 
8), into ~70-nucleotide pre-miRNAs, which fold into imperfect stem-loop 
structures. The pre-miRNAs are then exported into the cytoplasm by the RanGTP-
dependent transporter exportin 5 and undergo an additional processing step in 
which a double-stranded RNA of 19-23 nucleotides in length (referred to as the 
miRNA:miRNA* duplex) is excised from the pre-miRNA hairpin by Dicer, the 
RNAse III enzyme. Subsequently, the miRNA:miRNA* duplex is incorporated 
into the RNA-induced silencing complex (RISC), which uses the mature miRNA 
guide strand as a template to identify target mRNA. The functional miRNA strand 
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is preferentially retained in the miRISC complex and negatively regulates its 
target genes. Either strands, -5p or 3P, can be functional depending on the tissue 
or cell condition [24-27]. 
MicroRNAs Function 
It is widely accepted that miRNA binds to its target mRNA and negatively 
regulates its expression with the final effect of reducing the total amount of target 
protein. However several lines of evidence supports the existence of two distinct 
silencing mechanisms, depending on the miRNA and the cell type; in some cases, 
miRNAs have been shown to repress target gene expression at the translational 
level, whereas in the other cases miRNAs trigger the degradation of target 
mRNAs, both ultimately leading to down-regulation of gene expression [23, 28]. 
So far, the detailed mechanisms of gene silencing by miRNAs remain elusive. The 
translational repression by miRNAs might be due to the inhibition of translation 
initiation [29, 30] or the inhibition of elongation [31] or the enhancement of 
ribosomal drop-off from translating polysomes. Endogenous miRNAs are, indeed, 
associated with translating polysomes, thus suggesting that miRNAs may inhibit 
ribosome movement along mRNAs [32].  
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Figure 1. Biogenesis of miRNAs.  
Refer to the text for details. From Barca-Mayo O. et al., Front Neurosci. 2012; 6: 13. 
 
It has been demonstrated that miRNAs and their target mRNAs 
accumulate in cytoplasmic compartments referred to as processing bodies (P-
bodies) or, more broadly, stress granules where mRNA turnover occurs. These 
cytoplasmic granules are major sites where cleavage and degradation of mRNA 
occurs. A model for miRNA function has been described in which miRNA targets 
associate with Argonaute proteins (AGO) via miRNA:mRNA base pairing 
interactions. The GW182 protein, a major component of P-bodies, interacts with 
AGO and recruits deadenylase and decapping enzymes leading to degradation of 
mRNA [33]. The evidence that the inhibition of essential structural components of 
P-bodies leads to both a loss of P-bodies and also an impairment of miRNA 
function, further supports this model [34]. P-bodies also serve as sites for storage 
of repressed mRNAs: indeed, the entry of an mRNA into a P-body does not 
inevitably lead to its degradation and repression by miRNA can be a reversible 
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process. An important new hypothesis is that mRNAs may return to polysomes to 
synthesize new proteins and that certain cellular proteins may facilitate the exit of 
mRNA from P-bodies. For example, the CAT-1 mRNA, negatively regulated by 
miR-122a, escapes both translational repression and P-body entrapment following 
amino acid starvation, oxidative stress or endoplasmic reticulum stress. Following 
depression, the CAT-1 mRNA is released from the P-bodies and is recruited by 
polysomes, where it is actively transcribed [34, 35]. 
Although miRNAs are mainly reported as negative regulators of mRNA 
translation there are few studies showing that under certain conditions miRNAs 
can also enhance the translation of target mRNAs [36, 37]. Translation 
upregulation by miRNAs might occur by two different mechanisms: activation by 
a direct action of miRNA on the target mRNA [38] or relief of a strong repression 
of the mRNA translation [39]. However, the physiological impact of such modes 
of regulation remains to be determined. 
MicroRNAs Target Genes 
It is estimated that the expression of at least 60% of human genes is 
subjected to miRNA-regulated process; it is evident that the identification of 
miRNA-target genes holds the key to decipher the molecular mechanisms by 
which miRNA exert their biological functions. Computational algorithms have 
been the major driving force in predicting miRNA targets. These approaches are 
mainly focused on programming alignment to identify complementary elements in 
the 3′-UTR with the seed sequence of the miRNA and the phylogenetic 
conservation of the complementary sequences in the 3′-UTRs of orthologous 
genes. However, evidence suggests that perfect seed pairing may not necessarily 
be a reliable predictor for miRNA interactions [40-42], which may explain why 
some predicted target sites are non-functional. 
Based on the experimentally validated miRNA:mRNA interactions, the 
following general rules have been recognized: (i) miRNAs regulate the expression 
of target genes by forming perfect or imperfect base-pair interactions with them; 
(ii) multiple miRNA binding sites in the target UTRs might be required for 
efficient regulation; (iii) miRNAs and their target sites are evolutionarily 
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conserved among related species; (iv) an effective miRNA:mRNA interaction 
needs an open structure on the target site to begin the hybridization reaction [42, 
43]. Furthermore, the ‘core sequence’ in the mRNA 3’UTR, that forms perfect or 
near-perfect base pairs with seven or eight bases near the 5′end of its miRNA 
cognate (called the ‘seed region’), seems to be crucially important for mediating 
miRNA inhibitory activity [44].  
Once the potential physical interactions between miRNAs and mRNA 
targets have been predicted by bioinformatics tools, the predicted putative miRNA 
target(s) must be validated, usually via luciferase reporter, gain/loss of function 
and ribonucleoprotein immunoprecipitation (RIP) approaches [41, 45]. 
MicroRNAs as regulators of Toll-like receptors (TLRs) signaling 
Toll-like receptors (TLRs), a family of pattern recognition receptors 
(PRRs), play a crucial role in early host defense against invading pathogens, given 
their ability to activate innate immune responses to provide effective host defense 
against pathogen infections. However, TLR-signaling pathways are also likely to 
stringently regulate tissue maintenance and homeostasis by elaborate modulatory 
mechanisms. Recent studies, performed mainly in monocytes/macrophages, have 
indicated that miRNAs play important roles in regulating the TLR-signaling 
pathways and innate immune responses and function as an essential part of the 
networks involved in regulating TLR-signaling pathways. [46]. In 2006, 
Baltimore Lab first documented that stimulation of human monocytes with 
lipopolysaccharide (LPS) upregulates the expression of miR-146a, miR-155, and 
miR-132 [47].  In turn, miR-146 functions as the effector arm of a negative 
feedback mechanism regulating TLR signaling in response to bacterial products, 
thus preventing the risk of excessive inflammation [48]. Subsequent studies 
showed an increase in expression of many other miRNAs. To date, an array of 
miRNAs are involved in regulating of the TLR-signaling pathways and innate 
immune responses by targeting multiple molecules at multiple levels, including 
TLRs themselves, TLR-associated signaling proteins, TLR-associated regulatory 
molecules, TLR-induced transcription factors, and TLR-induced functional 
cytokines (Figure 2) [49].  
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Collectively, these studies indicate that TLR signaling pathways induce 
multiple miRNAs, which in turn regulate the strength, location, and timing of the 
TLR signaling pathways, and might be involved in controlling the switch from a 
strong early inflammatory response to the resolution phase of the inflammatory 
process in a timely and orchestrated manner. The innate immune system utilizes 
multiple miRNAs to properly regulate its functional capacity, creating a finely 
tuned balance between activation and repression in TLR-signaling pathways. 
Nevertheless, the mechanisms regarding TLR-signaling pathways mediated 
miRNA expression regulation, through transcriptional repression or 
posttranscriptional destabilization, need to be further deeply investigated. 
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Figure 2. The fine-tuning of the TLR-signaling pathways by miRNAs. 
Refer to the text for details. From He X. et al. Biomed Res Int. 2014; 2014: 945169. 
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MicroRNAs in Neutrophils 
The literature addressing the roles of miRNAs in neutrophil biology is 
relatively scarce to date. This may be attributed to the obvious challenges 
associated with in vitro studies of purified primary neutrophils.  
The majority of the miRNA studies on human neutrophils are focused on 
neutrophil development and are performed in  neutrophils from mice  deficient of 
specific miRNAs, such as miR-223-deficent mice [50], or with myeloid-specific 
Cebpa-Cre Dicer1 deletion [51]. Future work is needed using neutrophil-specific 
Dicer knock outs to differentiate between the role of miRNAs in neutrophil 
development and effector function. Meanwhile, a few specific miRNAs have been 
implicated in neutrophil biology, although their regulatory mechanisms are not 
fully elucidated (Figure 3) [52, 53]. Whether the biological relevance of the 
findings arising from such mouse models aids our understanding of human 
neutrophils is an open question, given the vast differences between human and 
mouse neutrophils. miR-223 was originally found to be restricted to myeloid cells 
(Gr-1+ and Mac-1+) [54], subsequently it was shown to be one of the most 
abundant miRNAs expressed by human granulocytes (CD15+) [55],  and it has 
been shown to act as a negative modulator of neutrophil activation. In fact, 
neutrophils from miR-223 deficient mice are hypersensitive to activating stimuli 
[50] (Figure 3). Of considerable importance is the role of miR-4661 in 
inflammation, as Li et al. [56] demonstrated that miR-4661 overexpression in 
murine bone marrow neutrophils promotes the initiation of inflammation, 
characterized by a significant increase in leukocyte infiltration. In murine bone 
marrow neutrophils, miR-466l overexpression increased amount of IL- 1β, TNF-
α, IL-10, accompanied with increased chemotaxis to C5a and TNF-α, as well as 
increased reactive oxygen species production [56]. In the model proposed in this 
study, miR-466l serves as a signaling molecule that is initially expressed in 
neutrophils to promote the initiation of inflammation, but is then upregulated in 
macrophages to resolve the inflammation. Interestingly, miR-466l increases target 
gene expression through stabilization of its mRNA targets, opposite to the role for 
the vast majority of other miRNAs. Finally, miR-451 has been shown to 
negatively regulate mouse and human neutrophils chemotaxis in vitro by 
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downregulating the p38 MAPK signaling pathway [57] (Figure 3). Yang et al. 
[53] provided some evidence that decreased miR-150 in neutrophils after 
traumatic injury may up-regulate the protein kinase C alpha (PRKCA) expression. 
This protein has several cellular functions, such as cell adhesion, secretion, 
proliferation, differentiation, and apoptosis, and its increased level results in 
neutrophil activation related to traumatic injury [53].  
 
 
Figure 3. Individual miRNAs that regulate neutrophil functions intrinsically.  
miR-451 inhibits chemotaxis by inhibiting the p38 MAPK pathway. miR-466l performs 
non- canonical functions to upregulate gene expression by binding to AU- rich elements 
in the 3′UTR of target mRNA and prevents their degradation. miR-223 is involved in 
neutrophil maturation. miR-142 promotes neutrophil development and function through 
unknown direct targets. 5′ strand (red), 3′ strand (blue), hairpin and lower stem (gray), 
gene exon (dark green), non- coding exon (light green). Mature strand is indicated in 
cytoplasm. From Gurol T. et al., Immunol Rev 2016; 273: 29-47. 
 
To our knowledge, only one miRNA has been described so far as 
upregulated by LPS in human neutrophils. In fact, our group identify miR-9 as the 
only miRNA (among 365 analyzed using a TaqMan-based Low Density Array) 
up-regulated in both human neutrophils and autologous monocytes after TLR4 
activation. miR-9 is also induced by TLR2 and TLR7/8 agonists and by the 
proinflammatory cytokines TNF- and IL-1. Our data showed that TLR4-
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activated NF-B rapidly increases the expression of miR-9, that operates a 
feedback control of the NF-B-dependent responses by fine tuning the expression 
of p50, a key member of the NF-B family [58].   
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2. Aim of the Study  
The main purpose of this thesis has been to provide a comprehensive 
characterization of the miRNome of primary human neutrophils freshly purified 
from peripheral blood of healthy subjects and/or kept in culture in the presence or 
absence of LPS.  
With the aim of characterizing other miRNAs involved in neutrophil 
function, several studies have attempted to determine the profile of miRNAs 
expressed in neutrophils. Three main approaches have been adopted to date to 
profile miRNAs in neutrophils and progenitors: miRNA microarrays, miRNA 
cloning/sequencing, and low-density miRNA PCR arrays. The most popular is 
that of miRNA microarrays, allowing for the rapid characterization of 
differentially expressed miRNAs between samples. It is worth noticing that none 
of these studies addressed the question of the role of miRNAs in TLR4-mediated 
activation of human neutrophils.  
We have previously conducted a TaqMan-based Low Density Array to 
profile the miRNAs (out of the 365 mature miRNAs included in the array) 
constitutively expressed and induced by LPS in human neutrophils [58]. A more 
accurate picture of miRNAs expressed in neutrophils can be obtained by the 
RNA-sequencing strategy. In fact, RNAseq data over the Low Density Array that 
we have previously utilized provides several advantages: 
1. RNAseq outperforms array platforms in several respects, notably in exon 
boundary detection and dynamic range of expression;  
2. RNAseq can be employed in the discovery of new transcripts;  
3. Another drawback of the array platforms is the limited dynamic range of 
detection [59]. Previous work has presented RNAseq data with a dynamic 
range varying over 5 orders of magnitude [60]. Consistent with this, ~40% 
more genes are called differentially expressed by RNAseq between two 
distinct subpopulations, even when using a conservative statistical test. It 
is also clear that the fold difference of differential expression is greater for 
RNAseq; 
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4. RNAseq allows the characterization of the whole transcriptome, thus it is 
informative not only of non-coding RNA but also of protein-coding gene 
expression. Transcriptome analysis of protein-coding genes may represent 
a useful tool for the subsequent identification of miRNA targets;  
5. Advances in high-throughput deep sequencing of the transcriptome and 
the ENCODE project have led to the discovery of numerous new 
noncoding RNAs as compared to those deposited in the database few years 
ago and present in the array. 
The study was performed in parallel on human neutrophils and autologous 
monocytes. Such a concurrent analysis was planned in order to identify shared 
and/or cell specific pathways regulated by miRNAs. In this context, our 
understanding of the molecular bases of gene expression in neutrophils as 
compared to monocytes is still poor, possibly due to the objective difficulties in 
isolating these cells at high purity and manipulate them in culture, issues that are 
particularly critical in human samples. For this reason, this study had two 
additional technical goals: (i) to develop an optimized protocol allowing us to 
immunoprecipitate the RISC-associated Ago proteins to integrity and to 
simultaneously detected RISC-associated miRNA/mRNA in neutrophils; (ii) to 
validate miRNAs predicted target genes directly in primary human neutrophils 
overexpressing the identified miRNA. 
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3. Materials and Methods 
3.1. Materials 
Ultra Pure E. coli lipopolysaccharide (LPS, 0111:B4 strain) and 
polyinosinic:polycytidylic acids [poly(I:C)] purchased from Invivogen (San 
Diego, CA, USA). Rabbit anti-Ago antibody (clone 2A8) purchased from 
Millipore, (Darmstadt, Germany) and rabbit anti-Actin Antibody (A2066) from 
Sigma-Aldrich (Saint Louis, MO, USA). Pre-miR miRNA precursor and the 
negative control 2 were bought from Ambion, Thermo Fisher. 
3.2. Cell purification and culture 
The purity of the cell populations constitutes an important concern for all 
gene expression studies conducted by real-time PCR approach. In fact, on one hand 
the development of real-time PCR-based techniques for measuring gene expression 
requires less RNA template than other methods of gene expression analysis and 
allows a reliable quantification of RT-PCR products; however, on the other hand, 
because of its extremely high sensitivity, it can easily amplify mRNA from a few 
contaminating leukocytes eventually present in neutrophil or monocyte 
preparations. In particular, this represents a major concern for molecular studies 
conducted on neutrophil, because peripheral blood mononuclear cells (PBMCs) 
possess 10–20 times more RNA per cell than neutrophil, and synthesize 10- to 300-
fold more cytokine than neutrophil so that a contamination of only 1% PBMCs can 
translate into an up to 20% of contamination at the RNA level. Therefore, it is 
critical to work with highly purified neutrophil populations and to generate 
substantial evidence that mRNA expression can be directly attributed to neutrophil, 
as opposed to contaminating PBMC or even eosinophils [61]. For these reasons, the 
entire study has been performed on highly pure human neutrophil, separated by 
centrifugation on Ficoll-Paque Plus (GE Healthcare, Little Chalfont, 
Buckingamshire, UK) and enriched to reach a 99.9% purity by positively removing 
eventual contaminating cells (T cells, NK cells, B cells, monocytes, DCs, platelets, 
eosinophils, or erythrocytes) with Abs against CD3, CD56, CD19, CD36, CD49d, 
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and Gly-A using a custom-made EasySep kit (StemCell Technologies, Vancouver, 
Canada). Monocytes were isolated from PBMC after centrifugation over Percoll 
gradients and then purified at the 99.8% by negative magnetic selection with 
MACS Human Monocyte Isolation Kit II (Miltenyi Biotec, Bergisch Gladbach, 
Germany). The purity of both leukocyte populations was assessed by flow 
cytometry using Abs against CD3 for the detection of lymphocytes, anti-CD14 Abs 
for monocytes, anti-CCR3 Abs for eosinophils and anti-CD16 or anti-CD66b for 
neutrophil. Neutrophil (6x106/ml) and monocytes (3x106/ml) were then 
resuspended in RPMI 1640 medium (BioWhittaker, Walkersville, MD, USA) 
supplemented with 10% low endotoxin FCS (BioWhittaker; <0.06 EU/ml by 
Limulus amebocyte lysate assay) and 2 mM L-glutammine (Cambrex). Cultured 
cells were treated with 100ng/mL LPS or 50 µg/mL poly(I:C), according to the 
conditions and times indicated in the Results. 
At the indicated times after stimulation, ice-cold PBS was added, cells 
were then collected, centrifuged twice at 500 x g for 5 min at 4°C and then 
manipulated as described in the sections below. All reagents were of the highest 
available grade and buffers were prepared with pyrogen-free water for clinical 
use. 
3.3. Purification and quantification of total RNA 
Total RNA was extracted from monocytes using the RNeasy Mini Kit 
(QIAGEN, Crawley, UK), according to the manufacturer’s protocols. Total RNA 
was quantified by Nanodrop 2000c spectrophotometer (Thermo Fisher) and 
checked for the integrity by Agilent 6000 Nano (cat. no. 5067–1511) kit in an 
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). 
3.4. Real-time RT-PCR (RT-qPCR) of mRNAs and pri-miRNAs 
The expression of NFKB1, TNFα, GNB2L1, RPL32, Fas mRNA, and the 
precursors of selected microRNAs was quantified by RT-qPCR using gene-
specific primer pairs reported in Table 1 for mRNAs and supplementary Table S1 
for the pri-miRNAs.  
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Table 1. Primers used in RT-qPCR analysis for mRNAs.  
 
Total RNA samples were reverse transcribed using 5ng/µL random 
primers, 0,5 mM dNTPs, 10 mM DTT, 1X reverse-transcription buffer, 1 U/µL 
RNase inhibitor (RNAse Out, Invitrogen) and 5 U/µL reverse transcriptase 
(SuperScript III, Invitrogen) at 50°C for 60 min. 
Gene expression was evaluated in duplicate from 10 ng of cDNA using the 
FastSYBR Green Master Mix (Applied Biosystem, ThermoScientific) in the 
presence of 200 nM specific primer pairs, using the ViiA7 qPCR system (Applied 
Biosystem, Thermo Fisher). Data were calculated with LinReg PCR 7.0 and Q-
Gene software (www.biotechniques.com) and then expressed as mean normalized 
expression (MNE) units after GAPDH normalization. Briefly, LinReg was used 
for the calculation of the amplification efficiency of each gene; subsequently the 
MNE with standard deviations (SD) for each sample and corrected for 
amplification efficiencies were calculated using the Q-Gene software. 
3.5. RT-qPCR analysis of miRNA expression 
Single miRNA expression analysis were performed by TaqMan® miRNA 
Human Assay (Applied Biosystems). cDNA was synthesized from 100 ng of total 
RNA using TaqMan® microRNA reverse transcription kit (Applied Biosystems, 
Thermo Fisher) and individual miRNA-specific RT primers contained in the 
Target Sense Oligonucleotide Antisense oligonucleotide 
NFKB1 (57bp) GGGCAGGAAGGACCTCTAG ACGGTGTGGGAAATTGTCAG 
NFKB1 (325bp) CCTGAGACAAATGGGCTACAC TTTAGGGCTTTGGTTTACACGG 
TNFα (70bp) TTGACACAAGTGGACCTTAGG CTGGGCTCCGTGTCTCAAG 
TNFα (243bp) GAGCACTGAAAGCATGATCC CGAGAAGATGATCTGACTGCC 
GNB2L1 (61bp) GACAACCTGGTGCGAGTGTG GCTCTGCCATAAACTTCTAGC 
GNB2L1 (225bp) TAGTTTCTCTAAGCCATCCAGTG ATTCCATAGTTGGTCTCATCCC 
FAS (73bp) CCTACTTCTTTCTCAGGCATC AAATGGAGAGGTGGCAAAGC 
RPL32 (183bp) AGGGTTCGTAGAAGATTCAAGG GGAAACATTGTGAGCGATCTC 
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TaqMan® microRNA Human Assays according to the manufacturer’s protocol. 
The reaction was incubated for 30 min at 16ºC, 30 min at 42ºC and 5 min at 85ºC. 
Each generated cDNA was amplified in duplicate by qPCR with sequence-
specific primers from the TaqMan® microRNA Human Assays, according to the 
manufacturer instructions, on the ViiA7 qPCR system (Applied Biosystems, 
Thermo Fisher). The reaction was incubated at 50°C for 2 min, followed by 95°C 
for 20 s, and then by 50 cycles of 95°C for 1 s and 60°C for 20 s. The relative 
miRNAs expression value were calculated according to the "comparative Ct" 
method using RNU44 as endogenous control [62]. Briefly, ΔCt represents the 
threshold cycle (Ct) of the target miRNA minus that of reference small RNA and 
ΔΔCt represents the ΔCt of the treated sample minus that of the control sample. 
Relative miRNA expression has been expressed as fold change, FC = 2 –ΔΔCt. 
3.6. Cell lysis  
Cells were lysed with different lysis methods: using Polysome Lysis 
Buffer (PLB) or Nitrogen Cavitaion. PLB was used to lyse the cells as previously 
described [63], briefly, monocytes (15×106) and neutrophils (30×106) were lysed 
in polysome lysis buffer (100 mM KCl, 5 mM MgCl2, 10 mM Hepes, 0.5% 
Nonidet P-40) supplemented with 1,000 U/mL RNase Out (Invitrogen), 5 mM 
Vanadyl ribonucleoside complexes (VCR), 5 μg/mL leupeptin, 5 μg/mL pepstatin, 
1 mM phenylmethanesulphonylfluoride (PMSF), 1 mM Na3VO4, 20 μM 
phenylarsine oxide (PAO), 1mM DTT, and 50 mM NaF.  
Nitrogen cavitation was used to lyse the cells as described by P. Patrick et 
al. [64] with minor modifications. Briefly, cells (108 cells/mL) were suspended in 
ice-cold relaxation buffer (10 mM PIPES pH 7.30, 30 mM KCl, 3 mM NaCl, 3.5 
mM MgCl2, 1.25 mM EGTA) containing the same cocktail of antiproteases and 
antiRNases mentioned above for PLB. Then cells were pressurized under a N2 
atmosphere (350 psi, 20 minutes at 4 °C) with constant stirring in a nitrogen bomb 
(Parr Instrument Co, Moline, IL). Cavitate was spun for 10 min, 4 °C, at max 
speed; the granule-free cytoplasmic fraction was collected from the supernatant 
layer for further analysis. 
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3.7. Western blotting  
Lysates of cells from different lysis method, described above, were 
electrophoresed on 7.5% SDS-PAGE and transferred to nitrocellulose (Hybond, 
GE Healthcare, Little Chalfont, Buckinghamshire, UK).  The blots were incubated 
with 1:1000 rabbit anti-Ago Abs and 1:1000 rabbit anti-Actin Abs. Detection was 
carried out with Alexa FluorR 680 goat anti-rabbit secondary Abs (Molecular 
ProbesTM, Invitrogen, Carlsbad, CA). Blotted proteins were detected and 
quantified using the Odyssey infrared imaging system (LI-COR Biosciences, 
Lincoln, Nebraska). Quantification was performed with the analysis software 
provided by the manufacturer.   
3.8. Ribonucleoprotein Immunoprecipitation and Ago-Associated 
RNA Analysis 
Cells were lysed with PLB buffer or Nitrogen cavitation as described 
above and Ribonucleoprotein immunoprecipitation (RIP) experiments were 
performed as described elsewhere [65]. Briefly, immunoprecipitations were 
carried out for 3 h at 4 °C using protein G Sepharose magnetic beads (GE 
Healthcare) conjugated with anti-Ago (clone 2A8; Millipore) or isotype IgG1k 
control antibodies. An aliquot of IP supernatants, corresponding to 10% of cell 
equivalents, was removed after immunoprecipitation and used as input. Immune 
complexes were washed four times with NT2 buffer (50 mM Tris·HCl, 150 mM 
NaCl, 1 mM MgCl2, 0.05% Nonidet P-40 supplemented with 20 mM EDTA, 1 
mM DTT, 400 μM VRC, and 500 U/mL RNase Out) and were detached from 
beads with guanidinium-based lysis buffer (RLT buffer, RNeasy kit; Qiagen) 
supplemented with β-mercaptoethanol.  RNA then was extracted the input or 
immunoprecipitated samples with the RNeasy kit according to the manufacturer’s 
protocol. 
Detected RNA molecules (mRNA or miRNA) by RT-qPCR then were 
analyzed as follow: Ct values for replicate samples were first averaged, then each 
RIP RNA fractions’ Ct value was normalized to the Input RNA fraction Ct value 
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for the same qPCR Assay (ΔCt) to account for RNA sample preparation 
differences. 
 ΔCt [normalized RIP] = (Ct [RIP] - (Ct [Input] - Log2 (Input Dilution 
Factor))) 
 Where, Input Dilution Factor = (fraction of the input RNA saved) and the default 
Input fraction is 10% which is a dilution factor of 10.  
The normalized RIP fraction Ct value was then adjusted for the normalized 
background [non-specific (NS) isotype control Ab] fraction Ct value (ΔΔCt). 
ΔΔCt [RIP/NS] = ΔCt [normalized RIP] – ΔCt [normalized NS]  
Finally, the Assay Site IP Fold Enrichment was calculated above the sample 
specific background (linear conversion of the ΔΔCt). 
Fold Enrichment = 2 (-ΔΔCt [RIP/NS]) 
3.9. Flow cytometry 
For phenotypic studies  neutrophils (1x105 ) were initially incubated in 
PBS containing 5% complement-inactivated human serum (for Fc receptor 
blocking). Neutrophils were  then stained for 20 min at room tempreture with 
FITC anti-CD66b, PE anti-CD16 (BioLegend, San Diego, California, USA), 
APC-Cy7 anti-CD95 (Miltenyi Biotec, Bergisch Gladbach, Germany), and their 
related isotype controls. Sample fluorescence was then measured by using an 
eight-color MACSQuant Analyzer (Miltenyi), data analysis performed by FlowJo 
software Version 8.8.6 (TreeStar).  
Cell viability was analyzed using VybrantTM DyeCycleTM Violet-negative 
(Life Technologies, Carlsbad, CA, USA) [66]. Phenotypic analysis was performed 
on live cells, identified as Vybrant-negative cells. 
3.10. Neutrophils transfection 
Freshly purified neutrophils (12x106) were transfected with the indicated 
amount of Pre-miR miRNA precursor or the negative control (pre-miR-Ctr), using 
the Amaxa Nucleofector (Amaxa Biosystems GmbH) and the Human Monocyte 
Nucleofector kit (Lonza), according to the manufacturer’s protocol. Transfected 
31 
 
cells were plated in recovery medium (Amaxa) supplemented with 2 mM 
glutamine and 10% FCS and cultured for 6 h later as indicated. 
3.11. RNA sequencing 
Total RNA was extracted from monocytes and autologous neutrophils as 
described before and libraries were constructed following the manufacturer’s 
protocol of the TruSeq RNA sample preparation kit (Illumina). Briefly, after 
oligo-dT selection, mRNA was fragmented, double-stranded cDNA generated 
from fragmented RNA and index-containing adapters were then ligated to the 
ends. Libraries were evaluated using Agilent Bioanalyzer, quantified with the 
Qubit fluorometer using the quant-it HS dsDNA reagent kit (Invitrogen), and 
diluted according to Illumina’s standard sequencing protocol. High-throughput 
sequencing was done on an Illumina HiSeq 2000 platform in order to obtain an 
average of 50x106 51-base-pair (bp) paired-end reads. 
After quality-filtering according to the Illumina pipeline, short reads were 
aligned to the GrCh38 reference human genome (Genome Reference consortium) 
and the H. sapiens transcriptome (Ensembl, version 78) using TopHat [67] with 
the following parameters: -r 250 –p 8 –G. Summed exon reads count per gene 
were estimated using HTSeq-count [68] with the following parameters: -r name –
s no – m union –t exon –i gene. Differential expression analysis was performed 
using the negative binomial distribution-based method implemented in DESeq2 
on the summed exon reads count per gene [69]. Genes with adjusted p-value<0.05 
and |log2FC|>1 were considered as differentially expressed. Gene expression 
levels were expressed as fragments per kilobase of exon per million fragments 
mapped (FPKM), calculated by using DESeq2 functions. 
3.12. Gene ontology (GO) analysis 
PANTHER database (Version 11.1) was used for Gene Onthology (GO) 
analysis of the potential targets of the differentially expressed miRNAs, in order 
to identify the GO terms related to Biological Processes (BP).  
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3.13. Statistical analysis 
Data were expressed as mean ± SEM, unless otherwise indicated. 
Statistical evaluation was determined using the Student t-test or two-way analysis 
of variances (ANOVA) followed by Bonferroni post-test. P-values lower than 
0.05 were considered significant. Statistical analysis was performed by using 
Prism, version 6.0, software (GraphPad Software, La Jolla, CA, USA). 
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4. Results 
4.1. Characterization of the pri-miRNome of human neutrophils 
under resting and LPS-activated conditions.  
Neutrophils (99.9% pure), purified from six independent healthy donors 
were immediately lysed or  cultured in the presence or absence of 100 ng/mL LPS 
for 90 min and 4h. In order to obtain additional information helping us to better  
characterize the neutrophil miRNome, autologous CD14+ monocytes were 
purified, immediately lysed or stimulated with LPS (100 ng/mL) for 90 min and 
4h. Cells were collected at the selected time points and processed for RNA 
purification. Purified RNA from the six donors was subsequently merged in two 
pools of three independent samples each. Two cDNA pair-end libraries, 
representing the poly-A-positive RNA molecules, were generated and sequenced. 
Reads were quality filtered and aligned to the reference human genome (GrCh38 
– Ensamble77) as described in Materials and Methods. All data were subjected to 
differential gene expression (DGE) analysis by using DeSeq2. Expression profile 
of the pri-miRNAs annotated in miRBase sequence database was extracted from 
RNAseq data (Figure 4). 
This analysis allowed us to characterize the pri-miRNome of human 
neutrophils and autologous monocytes under resting and LPS-activated 
conditions. Under resting conditions 381 pri-miRNAs were detected (FPKM>0) 
in neutrophils (supplementary Table S2). Among these, 56 pri-miRNAs in 
neutrophils were found modulated (up-regulated FC>2, p<0.05; down-regulated 
FC<0.5, p<0.05) by LPS at either time point (90 min and/or 4h) as compared to 
freshly purified cells (Figure 5). Additionally, de novo expression of 3 pri-
miRNAs in neutrophils that were not detected in freshly purified cells (namely 
MIR9-1, MIR193A and MIR6772) was  triggered by TLR4 activation (Figure 5).  
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Figure 4. RNA sequencing workflow. Identification of miRBase annotated 
transcript 
CD14+ monocytes and autologous neutrophils were cultured for 90 min or 4h with LPS 
(100 ng/mL) or left untreated. After RNA purification, two pools of three donors for each 
condition were used to create polyA library for RNA-sequencing. Good quality reads 
(50x106/condition) were aligned on the human reference genome (GrCh38) and used for 
the differential gene expression analysis as described in Materials and Methods. 
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Figure 5. LPS stimulation modulates pri-miRNA expression in neutrophils.  
Hierarchical Clustering Analysis of pri-miRNA expression in neutrophils freshly purified 
or cultured for 90 min and 4h in the presence or absence of LPS. The expression levels of 
LPS-modulated pri-miRNAs (|Log2FC|>1, Pval<0.05) in neutrophils are shown as 
Log10(FPKM+1), centered to the mean across the genes in row.  
 
 
LPS-modulated pri-miRNAs were clustered based on their kinetic of 
expression (Figure 6): 
1. Primary and transient: pri-miRNAs whose expression is rapidly modulated 
by LPS at 90 min, and returns to the basal level within 4h; 
2. Primary: pri-miRNAs whose expression is modulated by LPS at 90 min 
and keeps the trend of modulation at later time point (4h); 
3. Secondary: pri-miRNAs whose modulated expression is detectable 4h post 
LPS stimulation. 
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Figure 6. LPS modulates the expression of pri-miRNAs with three different 
patterns: primary and transient, primary and secondary.  
LPS-modulated pri-miRNAs identified in neutrophils were clustered into primary and 
transient (A), primary (B) and secondary (C) according to their kinetic of expression. The 
expression levels of LPS-modulated pri-miRNAs belonging to each category are shown 
as Log10(FPKM+1), centered to the mean across the genes in row. The percentage of pri-
miRNAs belonging to each category is shown in panel D.  
 
 
4.2. MiRNA transcripts selectively expressed in resting and LPS-
activated neutrophils  
Determining the specificity of miRNA expression profiles in neutrophils is 
clearly important for understanding the biology of this innate immune cells, that 
are characterized by unique functions and, correspondingly, distinct gene 
expression profiles. In order to identify neutrophil-specific pri-miRNAs 
modulated by LPS, we took advantage of the RNAseq performed in autologous 
CD14+ monocytes. RNAseq data were processed according to the same strategy 
employed for neutrophils (Figure 4). Differential expression of pri-miRNA in 
resting vs activated monocytes was performed with DESeq2, and showed that 70 
pri-miRNAs are modulated (up-regulated FC>2, p<0.05; down-regulated FC<0.5, 
p<0.05) in LPS-stimulated monocytes at either time point (90 min and/or 4h) as 
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compared to freshly purified cells (Supplementary Figure S1). Additionally, de 
novo expression of 14 pri-miRNAs in monocytes (namely MIR146B, MIR4726, 
MIR3065, MIR4637, MIR181C, MIR181D, MIR4470, MIR4524A, MIR4773-2, 
MIR5696, MIR6772, MIR760, MIR7976, MIRLET7G) was triggered by TLR4 
activation (Supplementary Figure S1).  
Comparison between LPS-modulated pri-miRNA in neutrophils and 
monocytes allowed us to identify the following categories (Figure 7):  
 31 pri-miRNAs specifically modulated by LPS only in neutrophils. 
Precisely, 13 pri-miRNAs increased and 18 pri-miRNAs decreased in 
LPS-stimulated as compared to freshly purified neutrophils. 
 56 pri-miRNAs specifically modulated by LPS only in monocytes: 39 pri-
miRNAs increased and 17 pri-miRNAs decreased in LPS-stimulated as 
compared to freshly purified monocytes. 
 21 pri-miRNAs modulated by LPS in a shared manner in both neutrophils 
and monocytes (i.e. up-regulated or down-regulated by LPS in both cell 
types);  
 7 pri-miRNAs with opposite type of LPS-dependent modulation in 
neutrophils and monocytes (up regulated in one cell type and down 
regulated in the other). 
The pri-miRNAs belonging to each above-mentioned categories are displayed in 
figure 7 as the Log2Foldchange of their expression in LPS condition compared to 
resting cells. To model the heatmap each pri-miRNAs with |Log2FC|>1 and 
Pval<0.05 was considered modulated and other than this condition was defined as 
pri-miRNA with no modulation (Log2FC=0).  
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Figure 7. Shared and cell type-specific pri-miRNAs modulated by LPS. 
Pri-miRNAs differentially regulated by LPS in neutrophils and monocytes were identified 
by DESeq2 and their regulation was compared between the two cell types. 31 pri-miRs 
were selectively modulated in neutrophils (A) and 56 selectively in monocytes (B). 21 
pri-miRs were found to be modulated with the same pattern (C) and 7 with the opposite 
pattern (D) among neutrophils and monocytes. Cell type-specific and shared LPS-
modulated pri-miRNAs are presented as Log2FC (LPSvsT0). 
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4.3. Identification of pri-miRNAs upregulated by LPS in a TRIF-
dependent manner.  
LPS triggers different responses in neutrophils and monocytes, partly 
because of the selective activation of the different, MyD88- and/or TRIF-
dependent, signaling pathways downstream of the pattern-recognition receptor 
TLR4 [70]. In neutrophils only the MyD88-dependent signaling is active, while in 
monocytes both these pathways are simultaneously activated downstream TLR4 
[71]. It is conceivable that the monocyte-specific pri-miRNAs are not upregulated 
in response to LPS in neutrophils because they are transcriptionally activated 
downstream MyD88-independent pathway, which is not active in neutrophils. To 
test this hypothesis, we initially validated in monocytes the pri-miRNAs identified 
in RNAseq analysis as upregulated by LPS. Monocytes were purified and 
immediately lysed or cultured in the presence or absence of LPS for 4h, and the 
expression level of the pri-miRNAs was assessed by RT-qPCR. Sixteen out of the 
thirty-nine LPS-induced pri-miRNAs were undetectable in RT-qPCR (Ct > 35 in 
all the conditions), mostly consistent with their very low level of expression in 
RNAseq (FPKM <2). Induction of seventeen pri-miRNAs was successfully 
validated (Figure 8A). Furthermore, the expression of seven pri-miRNA (namely 
MIR3065, MIR378D2, MIR6895, MIR4482, MIR29A, MIR657 and MIR4726) 
increased in monocytes cultured for 4h in medium alone, and the presence of LPS 
did not further enhance their expression. This observation suggests that the 
transcription of pri-miRNAs identified as LPS-induced (4h LPS-stimulated vs 
freshly purified cells) might be triggered by events other than TLR4 activation, 
and occurring during 4h culture (Figure 8B, C).  
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Figure 8. Validation of LPS-induced pri-miRNAs in monocytes. 
RNA was purified from freshly purified monocytes or from monocytes cultured for 4h in 
the presence or absence of LPS (100 ng/mL). LPS-induced pri-miRNAs expression was 
determined by RT-qPCR and normalized to RPL32 as described in Materials and 
Methods. The results are expressed as fold change (FC) of the pri-miRNA expression in 
LPS-stimulated (A) or control (B) condition versus freshly purified cells, or in LPS-
stimulated condition versus control cells (C). Data are shown as mean ±SEM of three 
independent experiments (ns P> 0.05, * P< 0.05, ** P< 0.01, *** P< 0.001). 
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Based on these observations, seven pri-miRNAs were then selected as 
LPS-induced (FC LPS vs medium >2): pri-miR-7976 (FC=2.2), pri-miR-6775 
(FC=2.8), pri-miR-4773-2 (FC=6.7), pri-miR-155 (FC=79.8), pri-miRNA-4470 
(FC=2.2), pri-miRNA-146b (FC=2.2) and pri-miRNA-6738 (FC=2.5) (Figure 
8C). We then investigated the requirement of MyD88 and/or TRIF adaptors in the 
induction of the miRNAs primary transcripts expression by LPS.  Monocytes 
were cultured in the absence or presence of LPS, or polyinosinic:polycytidylic 
acids [poly(I:C)] (50 μg/ml), a synthetic mimetic of viral double-stranded RNA 
(dsRNA) that interacts with endosomal TLR3 and utilizes TRIF-mediated 
signaling [70]. Poly(I:C) increased the expression of only MIR4773-2, indicating 
this pri-miRNA is transcriptionally induced downstream the TRIF pathway 
(Figure 9). Conversely, MIR155, MIR4470, MIR146b, MIR6775, MIR7976 and 
MIR6738, which were not induced by poly(I:C), are likely induced by LPS in a 
MyD88-dependent manner (Figure 9). 
 
 
 
Figure 9. pri-miRNA induction by TRIF-activating TLR agonist. 
Monocytes were cultured for 4h in the presence or absence of either LPS (100ng/ml) or 
Poly I:C (50ug/ml). RNA was extracted and the selected pri-miRNAs expression was 
determined by RT-qPCR. Pri-miRNA expression is depicted as fold change units after 
RPL32 normalization. Data are shown as mean ±SEM of three independent experiments 
(ns P> 0.05, * P< 0.05, ** P< 0.01, *** P< 0.001). 
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The identification of putative MyD88-dependent pri-miRNAs triggers the 
question of why these pri-miRNAs are not induced following LPS stimulation in 
neutrophils that can mobilize MyD88. To gain insights into the mechanisms 
responsible for the failure of LPS to upregulate the expression of MyD88-
dependent pri-miNAs in neutrophils, we analyzed the accessibility state of 
chromatin in the pri-miRNAs promoter regions. To this aim, we took advantage of 
H3K4me3-ChIP-seq (histone 3 Lysine 4 trimetylated chromatin 
immunoprecipitation-coupled with deep sequencing) data available in the 
laboratory, which was performed in neutrophils and monocytes incubated 
with/without LPS for 4 hours (Tamassia N. et al. unpublished). H3K4me3 is a 
very well-studied marker of active/poised promoter [72-74]. Promoter region for 
intragenic miRNAs was considered as the promoter of their host genes. The 
promoter region of MIR146b was predicted based on its transcription start site 
obtained from miRStrat (http://mirstart.mbc.nctu.edu.tw/), a database of miRNA 
transcription start site. As the promoter region of MIR4470 has not been yet 
studied, we analyzed the state of H3K4me3 upstream the miRNA sequence. 
The H3K4me3 state was analyzed in the region of the predicted promoters 
for MIR155, MIR4470, MIR6775, MIR7976, MIR6738 and MIR1446B (Figure 
10). H3K4me3 signals were not detected at the MIR155 putative promoter in 
resting and/or LPS-activated neutrophils, whereas monocytes activation triggered 
a strong increase of MIR155 promoter-bound H3K4me3 (Figure 10A). Histone 3 
embedded in the promoter region of MIR4470 was constitutively trimethylated 
and it significantly increased upon LPS-stimulation only in monocytes (Figure 
10B). Taken together, these results indicate that the chromatin at the promoters of 
MIR155 and MIR4470 is not accessible in neutrophils, thus explaining the failure 
of LPS to induce these MyD88-dependent pri-miRNA  
On the other hand, in the predicted promoter region of the other four 
MyD88-dependent pri-miRNAs we detected the same pattern of H3K4me3 in 
monocytes and neutrophils upon LPS-stimulation. Promoter region of MIR6775 
was enriched in H3K4me3 after LPS-stimulation in both cell types (Figure 10C). 
H3K4me3 was constitutively detected in the promoter of MIR7976, MIR6738 and 
MIR146B in both cell types and LPS did not change the pattern in these regions 
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(Figure 10D, E and F). A possible explanation for the failure of LPS to upregulate 
these pri-miRNAs in neutrophils may rely on the need for cell specific chromatin 
modifications which are required for transcriptional activation. 
Taken together these results indicate that TLR4 activation modulates 
microRNA expression profile in monocytes, and this modulation is precisely 
regulated for each microRNA via specific signaling pathways. 
 
 
 
 
Figure 10. H3K4me3 level at the MyD88-dependet miRNAs promoter region. 
Genome browser view of promoter locus for MIR155 (A), MIR4470 (B), MIR6775 (C), 
MIR7976 (D), MIR6738 (E) and MIR146B (F) are presented illustrating H3K4me3 
profile in monocytes and neutrophils freshly isolated or treated with 100ng/ml LPS for 
4h. 
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4.4. LPS-induced pri-miRNAs in neutrophils    
DGE analysis between neutrophils cultured for 4h in the presence or 
absence of LPS allowed us to identify LPS-modulated pri-miRNA in neutrophils. 
The primary transcript of let-7b was decreased (FC<0.5, p<0,05) and the primary 
transcripts for miR-146a, miR-221, miR-3945, miR-222, let-7i, miR-6821, miR-
3909, miR-4453, miR-27A, miR-24-2, miR-4645 and miR-23A were significantly 
increased (FC>2, p<0,05) upon LPS stimulation for 4 hours (Figure 11A). The 
increased expression of all LPS-induced pri-miRNAs was validated by RT-qPCR 
(Figure 11B). 
4.5. Mature forms of miR-23a cluster are increased by LPS 
Given the difficulties in working with low-level transcripts such as pri-
miRNAs and mature miRNA in neutrophils, we focused our subsequent analysis 
on those pri-miRNA that were detected at the highest levels in LPS-stimulated 
neutrophils. Among the twelve LPS-induced pri-miRNAs in neutrophils, 
expression of the miR-23a cluster primary transcript was detected at 189.5 FPKM 
in LPS-stimulated cells, as compared to the other pri-miRNAs whose expression 
didn’t exceed 35.5 FPKM. Two different mature and functional microRNAs, 
named  “3p” or “5p”, can generate from processing of a pri-miRNA Time-course 
analysis was performed to identify the mature forms of each of the miR23 cluster 
(miR-23a, miR-27a and miR-24-2) in neutrophils stimulated with LPS. Both 5p 
and 3p mature forms of each miRNA was detected in unstimulated neutrophils. 
Interestingly, the constitutive expression of these mature miRNAs decreased over 
time in unstimulated cultured cells (Figure 12). In the presence of LPS only the 
mature miR-23a-5p and miR-27a-5p were significantly upregulated, whereas none 
of the other miRNAs showed significant induction by LPS (Figure 12A-F).  
Consistent with previous data, these results indicate that each miRNA of the 
cluster is subjected to a specific individual maturation process [25, 26, 75, 76]. 
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Figure 11. LPS modulated pri-miRNAs in neutrophils.  
RNAseq data were analyzed in order to identify pri-miRNAs differentially modulated 
between neutrophils 4h in culture and 4h treated with LPS (|Log2FC|>1, p<0.05). 
Significantly modulated pri-miRNAs are presented by the Log2FC (4h LPS vs 4h Ctr) 
(A). Neutrophils were cultured for 4h in the presence or absence of 100ng/ml LPS, RNA 
was extracted and the expression of 13 selected pri-miRNAs were assessed by RT-qPCR 
and normalized to RPL32 expression. Fold change of expression is represented for each 
pri-miRNA in LPS treated neutrophil versus resting cells.  Data are shown as mean 
±SEM of three independent experiments (ns P> 0.05, * P< 0.05, ** P< 0.01) (B). 
46 
 
 
 
Figure 12. Detection of the mature miRNAs of the miR23a cluster.  
Neutrophils were cultured in the presence or absence of 100ng/ml LPS for indicated time 
points. RNA was extracted and the expression of mature forms of miR-23a cluster 
members was assessed by RT-qPCR. Expression was normalized to RNU44 as described 
in Materials and Methods. Mean normalized expression (MNE) is presented at each time 
in LPS treated (black bars) and resting neutrophils (white bars). Data are the shown as 
mean ±SEM of three independent experiments (** P<0.01, *** P<0.001). 
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4.6. LPS modulates FAS expression in neutrophils via increasing 
miR-23a 
Putative targets of miR-23a cluster 
To gain insight into the biological relevance of miR-23a-5p and miR-27a-
5p in LPS-stimulated neutrophils, microRNA target prediction databases, PicTar 
[77] and MiRanda [78], were interrogated. Putative targets commonly listed in 
both databases were identified and selected: 115 were predicted by both  PicTar  
and MiRanda as common putative targets of miR-23a-5p and  231  of miR-27a-
5p. The putative targets for each miRNA were then subjected to Gene Ontology 
(GO) terms association using PANTHER database (http://www.pantherdb.org/), 
and clustered according to the biological process (Figure 13). Genes in the GO 
subcategory 'immune system process' were then selected.  
The immune related targets for each miRNA in the GO subcategory 
‘immune system process’ are listed in the supplementary Table S3. Among all the 
immune related targets Fas was particularly interesting in the context of LPS-
stimulated neutrophils s. Fas is a death receptor from the tumor necrosis factor 
superfamily. Fas receptor ligation by FasL mediates cell apoptosis and a role for 
Fas in controlling neutrophil lifespan has been described [79].  
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Figure 13. GO term analysis of miR-23a-5p and miR-27a-5p putative targets. 
Targets of miR-23a-5p and miR-27a-5p commonly predicted by PicTar and MiRanda, 
were analyzed for GO biological process terms using PANTHER database. Identified GO 
terms are plotted based on the number of genes in each of the terms among the targets of 
indicated miRNAs. The red highlighted slices are related to the term ‘immune system 
process’ which are considered as immune related genes. 
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LPS modulates Fas protein expression in neutrophils 
In order to verify in silico miR-23a-5p and miR-27a-5p prediction, Fas 
protein  and  mRNA expression was initially analyzed in resting and LPS-
stimulated neutrophils (Figure 14). Neutrophils were freshly purified or cultured 
in the presence or absence of 100ng/ml LPS. Cells were harvested at 4, 8 and 24 
hours after stimulation and processed for Fas cytofluorimetric analysis and RNA 
purification .  Cytofluorimetric analysis of membrane Fas showed a significant 
decrease in Fas protein expression in LPS-stimulated neutrophils (Figure 14A and 
B). Conversely, LPS significantly increased Fas mRNA expression over 
unstimulated cells at each time point (Figure 14C). Remarkably, the rate of Fas 
mRNA and protein expression were inversely correlated (Figure 14D), thus 
suggesting that a post-transcriptional regulatory mechanism is likely in place. 
Most importantly, the viability of neutrophils cultured for 8h in the presence or 
absence of LPS was assessed by Vybrant DyeCycle Violet staining as described in 
Material and Methods. A significant decrease in the percentage of the apoptotic 
neutrophils was observed in the presence of LPS (Figure 15), describing the pro-
survival effect of LPS on neutrophils.  
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Figure 14. Fas mRNA induction by LPS is not paralleled by the protein 
induction. 
Neutrophils were cultured in the presence or absence of 100ng/ml LPS for indicated time 
points. Cells were stained with anti-Fas mAbs or negative control mAbs. Fas expression 
assessed by flow cytometry is presented as the peak intensity at 4h in resting and LPS-
stimulated neutrophils (A) or as the Mean Fluorescence Intensity (MFI) of Fas in 
indicated time points (B). RNA was extracted from the cells and the expression of Fas 
mRNA was assessed by RT-qPCR. Fas expression was normalized to RPL32 and is 
plotted as fold change (FC) of the level in LPS treated versus control cells in indicated 
time point (C). Fold change expression of Fas protein and Fas mRNA, in each time point, 
is reported for LPS treated versus resting cells (D). Data are the shown as ±SEM of three 
independent experiments (* P< 0.05, ** P< 0.01). 
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Figure 15. LPS protects neutrophils from apoptosis. 
Neutrophils (1x105) were cultured in the presence or absence of 100ng/ml LPS for 4 and 
8h. Cells were harvested at mentioned time and were stained with Vybrant DyeCycle 
Violet to assess their viability by flow cytometry analysis. Gating strategy was used to 
identify neutrophils. Viable neutrophils were gated as Vybrant DyeCycle negative (green) 
and apoptotic neutrophils were gated as Vybrant DyeCycle positive (red) in 8h control or 
LPS-stimulated condition. Data are shown as one representative of three independent 
experiments. SSC-A, side-scatter-area (A). The percentage of apoptotic cells in each time 
point in control or LPS condition are presented as the Mean ± SEM of three independent 
experiments (B) (** P< 0.01).    
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Optimization of the RIP assay in primary human neutrophils  
To proof a direct cause-effect link between the LPS-induced increase in 
miR-23a and miR-27a and the parallel decrease in Fas protein expression, we set 
up to perform a RIP assay in neutrophils. RIP is an assay which uses the stable 
physical association between the miRNA and the target mRNA to identify the 
miR–target interactions that occur in vivo. This assay has been successfully 
performed in many types of cell lines and primary cells. Nevertheless, performing 
RIP in neutrophils presents additional difficulties. In fact, the RIP protocol 
described in our previous work [65] in monocytes failed to produce the expected 
result in neutrophils since Ago proteins are degraded during the standard lysis 
procedure by the release of proteolytic activities that are normally stored in 
intracellular granules [16] (Figure 16A). In order to overcome this obstacle, 
neutrophils were lysed by nitrogen (N2) cavitation, which has been already shown 
to preserve protein integrity [16] (Figure 16A). Under these lysis conditions, 
protein integrity is preserved. We next checked the quality of RNA obtained from 
N2 neutrophil lysates. Microcapillary electrophoresis was performed using Agilent 
6000 Nano kit in an Agilent 2100 Bioanalyzer following the manufacturer’s 
directions. We used RNA purified with the RNeasy kit (Qiagen) as control for 
RNA integrity. Using nitrogen cavitation significantly decreased the RNA 
Integrity Number (RIN) to 3 (Figure 16C) from 8.7 of obtained by RLT buffer 
(Figure 16B), where a RIN of 1 represents almost fragmented and degraded RNA 
and a RIN of 10 represents intact and non-fragmented RNA [80]. In parallel, we 
show that RNA integrity remains quite the same for monocytes lysed with the two 
different methods (Figure 16D and E).  
Given that neutrophil proteins and mRNA cannot be purified to integrity 
simultaneously with a single lysis method, we planned to modify the condition for 
miRNA and mRNA detection in degraded samples. JN Rusell et al reported that  
amplicon with shorter length are better detected among degraded RNA [81]. On 
these bases primer sets able to generate amplicons of different length were tested. 
We reasoned that mRNAs recruited to the RISC complex might be protected from 
degradation. Therefore, primers were designed to target mRNA regions most 
likely to be included into the RISC, such as the 3’UTR region and regions 
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surrounding the predicted miRNA seed region (Table 1). Neutrophils stimulated 
with LPS were lysed by N2 cavitation. TNF-, NFKB1 and GNB2L1 mRNA were 
analyzed in RT-qPCR using the two different primer sets able to generate long or 
short amplicons (Figure 17A). As shown in Figure 17B, using these specifically 
designed primer sets we  succeeded in detecting mRNA in N2 neutrophil lysates.  
Our group previously reported that LPS induced miR-9 regulates the 
expression of NFKB1/p105 by directly targeting NFKB1 mRNA [58], meaning 
that NFKB1 mRNA should be recruited into the RISC in neutrophils after LPS 
stimulation. Based on these evidence, we checked the recruitment of miR-9 and 
NFKB1 into the RISC under the optimized condition for RIP assay in neutrophils. 
Neutrophils were purified and cultured for 4h in the absence or presence of LPS. 
Cells were lysed by N2 cavitation, and immunoprecipitation with anti-Ago or IgG 
isotype control was performed as described in materials and methods. RNA was 
extracted by RNeasy Mini Kit (QIAGEN) and miR-9 and NFKB1 mRNA 
enrichment was analyzed by RT-qPCR. Figure 18 shows the successful detection 
of RIP-associated miR-9 and NFKB1, which are enriched only in neutrophils 
stimulated with LPS.  
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Figure 16. Nitrogen Cavitation: the best substitution for PLB to lyse 
neutrophils. Monocytes and neutrophils (50x106 cells) were lysed with PLB or by N2 
cavitation. An aliquot of lysates corresponding to 3x106 cells were loaded on the gel and 
immunoblots were performed by Abs specific for Ago and αActin, followed by 
incubation with Alexa FluorR 680 goat anti-rabbit Abs. Shown is one experiment 
representative of three. The blots were scanned on the Odyssey Infrared Imaging System 
at 700 and 800 nm wavelengths (A). Neutrophil and monocytes were lysed by N2 
cavitation or RLT buffer (RNeasy kit, GIAGEN) as the positive control. RNA was 
isolated from both lysates by RNeasy Mini Kit (QIAGEN). RNA quality was checked 
using Agilent 6000 Nano kit in an Agilent 2100 Bioanalyzer. RNA Integrity Number is 
presented in each plot as RIN for neutrophil lysed with RLT (B) or N2 cavitation (C) and 
monocytes lysed with RLT (D) or N2 cavitation (E).  
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Figure 17. Primer sets amplifying short amplicons, successfully detect 
mRNAs in N2 neutrophil lysates.  
Two set of primers were designed to amplify short or long amplicons in selected 
genes. Schematic primer location and amplicon size are shown for each mRNA, 
primers with large amplicon size are shown in red and with short amplicon are 
shown in green (A). Neutrophils (50x106) were cultured in the presence of 
100ng/ml LPS for 4h. Cells were lysed by N2 cavitation and RNA was purified. The 
expression level of NFKB1, TNFα and GNB2L1 was assessed by RT-qPCR using both 
primer sets. The level of each mRNA is shown as Quantification Cycle (Ct) (B). Data are 
shown as mean ±SEM of three independent experiments.  
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Figure 18. NFKB1 mRNA and miR-9 simultaneously localize in Ago 
complexes.  
Freshly puriﬁed neutrophils were left untreated or were stimulated with 100ng/ml LPS for 
8 h. Cells were lysed with N2 cavitation for RIP assay and subjected to Ago or IgG 
(control) immunoprecipitation in parallel. The levels of NFKB1 (A) or miR-9 (B), were 
assessed by RT-qPCR, are expressed as normalized fold enrichment (FC) as described in 
Material and Methods, and are one representative of two independent experiments. 
 
 Enrichment of miR-23a and Fas mRNA into the RISC in LPS-stimulated 
neutrophils 
Using the optimized protocol, RIP was performed in order to analyze 
whether miR-23a and/or miR-27a and Fas mRNA are simultaneously recruited to 
the RISC complex upon LPS stimulation. Neutrophils were incubated with or 
without LPS for 8h. Cells were lysed using N2 cavitation and lysates were 
subjected to Ago immuno-precipitation. miR-23a and miR-27a  and Fas mRNA 
level then were analyzed by RT-qPCR in the RNA fraction extracted from Ago 
and IgG immunoprecipitates. A signiﬁcant recruitment of miR-23a-5p and miR-
27a-5p, to the Ago complexes, was observed in LPS-stimulated neutrophils, 
(Figure 19A and B). Simultaneously, mRNA encoding for Fas was also 
signiﬁcantly recruited to the Ago complexes upon LPS stimulation (Figure 19C), 
demonstrating that FAS gene is subjected to miRNA-mediated post-
transcriptional regulation miR-23a, miR-27a and Fas mRNA were not detected in 
RIP from unstimulated cells, nor in IgG control immunoprecipitates, thus 
excluding the possibility that the observed increase in miR-23a, miR-27a and Fas 
mRNA is caused by a general, nonspecific enrichment of mRNAs in Ago 
immunoprecipitates. 
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Overexpression of miR23a in neutrophils mirrors the effect of LPS on Fas 
expression 
To provide direct evidence for Fas as a physiologic target of miR-23a, in a 
complementary approach to RIP assay, we tested whether miR-23a 
overexpression can directly inﬂuence the levels of the endogenous Fas protein 
expression. Pre-miR™ miRNA precursors were transiently transfected into 
neutrophils. Success of the microRNA transfection was evaluated in a dose 
response overexpression experiment.  Freshly puriﬁed neutrophils were 
transfected with 50, 100 or 200 pmol of Pre-miR™ miRNA Precursor Molecules-
Negative Control 2 (pre-miR-Ctr), Pre-miR™ miR-23a-5p precursor molecule 
(pre-miR-23a) or Pre-miR™ miR-27a-5p precursor molecule (pre-miR-27a). 
Cells were lysed for RNA extraction and the expression of miR-23a-5p and miR-
27a-5p was detected Taqman miRNA assays.  A dose dependent increase in miR-
Figure 19. Fas mRNA and 
miR23a/27a simultaneously localize 
in Ago complexes.  
Freshly puriﬁed neutrophils were left 
untreated or were stimulated with 
100ng/ml LPS for 8 h. Cells were lysed for 
RIP assay and subjected to Ago or IgG 
(control) immunoprecipitation in parallel, 
as described in Section 3.10. The levels of 
the indicated miRNAs or mRNAs, were 
assessed by RT-qPCR, are expressed as 
normalized fold enrichment (FC) as 
described in Material and Methods, and are 
displayed as the mean ± SEM of three 
independent experiments for each panel. 
Asterisks indicate statistically signiﬁcant 
(*P < 0.05, *** P<0.001) difference 
between LPS-stimulated versus resting 
neutrophils. 
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23a and miR-27a was observed in neutrophils transfected with the pre-miRs as 
compared to the control pre-miR-Ctr (Figure 20A). The level of Fas mRNA 
(Figure 20B) and protein (Figure 20C and D) expression was then analyzed in 
neutrophils transfected with 200 pmol of miRNA precursors or relative negative 
control. Seven hours after transfection, miR-23a (Figure 20C), but not miR27a 
(Figure 20D), overexpression lead to a reduction in the expression of Fas protein 
while the expression of Fas mRNA remained comparable to that of pre-miR-Ctr-
transfected neutrophils (Figure 20B). The reduction of the Fas membrane protein by 
pre-miR-23a overexpression was reproduced in three independent experiments 
(Figure 20D). Taken together these data provide clear evidence for Fas expression 
to be regulated in neutrophils by LPS via miR-23a. 
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Figure 20. Overexpression of miR-23a in neutrophils mirrors the effect of 
LPS on Fas expression. 
Freshly puriﬁed neutrophils were transfected with the indicated amount (A) or only 
200pm (B, C, D) of pre-miR-Ctr, pre-miR-23a or pre-miR-27a. Cells were lysed for RNA 
extraction (A, B) or stained with anti-Fas/negative control mAbs for flow cytometry (C, 
D, E). The fold change expression of miRNAs normalized to RNU44 is represented 
versus their expression in cells transfected with pre-miR-Ctr (A). Fas mRNA expression 
relative to RPL32 is presented as MNE (B). Fas expression assessed by flow cytometry is 
presented for neutrophils transfected with pre-miR-Ctr or pre-miR-23a (C) and pre-miR-
27a (D). Mean Fluorescence Intensity (MFI) of Fas in transfected cells is represented as ± 
SEM of three independent experiments (E) (* p<0.05).   
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5. Discussion 
The role of miRNAs in the post-transcriptional regulation of protein-
coding gene expression is nowadays well established, and several works 
highlighted the involvement of these short non-coding RNA molecule in innate 
immunity [82-85]. Identification of miRNAs expressed in innate immune cells 
such as neutrophils and monocytes under different conditions has been addressed 
by several studies, which greatly increased our knowledge on the role of miRNAs 
in neutrophils and monocytes biology. However, these studies have been 
performed so far by TaqMan based arrays [58, 86, 87], miRCury LNA based 
arrays [88], miRNA microarrays [89-91] or nCounter platform [92]. Studies using 
small RNA-sequencing defining the differential microRNA profile in monocytes 
and macrophages have been performed [93, 94]. However, a thorough genome-
wide analysis of the transcriptional profile of miRNAs in neutrophils has not been 
performed yet. A limiting factor in high-throughput analysis of miRNA 
expression in neutrophils is represented by the low level of pri-miRNAs 
expression, by the very low RNA content of these cells (average 1 μg/107 cells), 
and by the considerable quantity of proteases stored in neutrophils’ granules. 
Thus, modulation of protein-coding gene expression at a post-transcriptional level 
in neutrophils is not the object of extensive investigation mainly for the 
difficulties of working with this type of cells, rather than for a scarce interest in 
neutrophils biology. Indeed, polymorphonuclear neutrophils, traditionally viewed 
as short-lived effector cells, are nowadays regarded as important components of 
effector and regulatory circuits in the innate and adaptive immune systems. Most 
of the physiological functions of neutrophils rely on their capacity to modulate the 
expression of a number of proinflammatory and immunoregulatory genes. This 
fact has reevaluated the importance, role, and physiological and pathological 
significance of neutrophils in the pathogenesis of inflammatory, infectious, 
autoimmune, and neoplastic diseases and has identified neutrophils as an 
important potential target for selective pharmacological intervention to both 
promote and restrain inflammation. In this context, understanding the mechanisms 
of modulation of gene expression represents a critical step toward a better 
understanding of how neutrophils may influence pathophysiological processes in 
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vivo. In this general scenario, this study represents the first high throughput 
analysis, performed using a deep sequencing-based strategy, that characterizes the 
pri-miRNA transcriptome of primary human neutrophils freshly purified or kept 
in culture under resting and/or LPS-stimulated conditions. To gain more insight 
on the functional relevance of the miRNAs identified, the same analysis has been 
conducted in parallel on autologous monocytes cultured under the same 
conditions as their neutrophil counterpart. These additional data should aid 
deciphering the role of certain miRNA selectively expressed in either cell type. 
MiRNAs are transcribed first as a long primary transcript, meaning that 
any regulation in miRNA expression at the level of transcription is firstly 
affecting the expression of pri-miRNAs. Additionally, it has been reported that the 
majority of pri-miRNAs are transcribed by RNA polymerase II, indicating that 
pri-miRNAs are structurally analogous to mRNAs and bear a 5ʹ 7-methyl 
guanosine cap and a 3ʹ poly-A tail [93, 95]. Accordingly, in order to identify 
miRNA repertoire responsive to LPS challenge in neutrophils we performed 
RNAseq based on a Poly(A) paired end library. In this study we detected 381 pri-
miRNAs expressed in freshly purified neutrophils, as compared to the 224 
detected by  TaqMan based array [87] and 282 detected by miRNA microarray 
[91] performed by other groups. RNAseq analysis of LPS-stimulated neutrophils 
showed modulation of 59 pri-miRNAs. A more detailed analysis of the LPS-
modulated pri-miRNA transcriptome, identified that LPS-modulated pri-miRNAs 
can be clustered according to their kinetic of expression. 66% of the pri-miRNAs 
can be rapidly modulated after 90 minutes of stimulation, after which pri-miRNAs 
expression return to the basal levels (primary and transient), or remains consistent 
over the time (primary); 34% of the pri-miRNAs are modulated after 4 hours of 
stimulation (Secondary). The kinetic of expression may be useful for the future 
identification of miRNAs function. 
Cell specific expression and function are of the well-known characteristics 
of microRNAs [96, 97]. Performing RNA-sequencing on autologous monocytes 
in parallel to neutrophils gave us also the opportunity to identify cell specific pri-
miRNAs, which might be related to specific responses of each cell type to LPS. 
We identified the expression of 31 pri-miRNAs modulated specifically in 
62 
 
neutrophils after LPS treatment compared to freshly isolated cells. In addition, we 
found that LPS specifically upregulates 39 pri-miRNAs in monocytes, seven of 
which were further validated by RT-qPCR as LPS-induced. It is conceivable that 
the monocyte-specific pri-miRNAs are not upregulated in response to LPS in 
neutrophils because they are transcriptionally activated downstream TRIF-
dependent pathway, which is not mobilized by TLR4 engagement in neutrophils. 
However, we found that only MIR4773-2 was found to be transcriptionally 
induced by LPS in a TRIF-dependent manner. Furthermore, we show that the 
chromatin at the promoters of pri-miR-155 and pri-miR-4470 is not accessible in 
neutrophils, thus explaining the failure of LPS to induce these MyD88-dependent 
pri-miRNA. A possible explanation for the failure of LPS to upregulate the 
remaining monocyte-specific MIR6775, MIR7976, MIR6738 and MIR146B 
primary transcripts in neutrophils may rely on the need for additional cell-specific 
chromatin modifications required for transcriptional activation.   
In neutrophils, twelve pri-miRNAs were identified as LPS-induced, among 
which the increase in the mature forms of the two members of miR23a cluster, 
miR-23a-5p and miR-27a-5p, was validated. miR23a cluster consists of miR-23a, 
miR-27a, and miR-24-2 which are highly conserved in different species [98] and 
are described to play important roles in various biological and pathological 
processes such as cell development [99], proliferation [100], differentiation [101], 
invasion and metastasis [102], immune response [103] and apoptosis [104]. 
miR23a cluster is described in various vertebrate cells and their function has been 
studied in different cell types [98], but their role in neutrophil has not been 
described yet. To gain insight into the biological role of miRNA, the identification 
of miRNA-terget gene(s) is mandatory. However, this is not an easy task as 
demonstrated by the limited number of bona fide miRNA targets that have been 
experimentally validated so far (DIANA TarBase database; Sethupathy et al. 
2006) [105]. 115 and 231 potential targets for miR-23a-5p and miR-27a-5p 
respectively were identified by PicTar and miRanda miRNA target prediction 
databeses. As a strategy to restrict the number of putative target to study, we 
focused on genes that fall in the cathegory of “immune-related” according to GO 
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term analysis. Among these, FAS was particularly interesting for neutrophil 
biology, and was choosen for the subsequent analysis.  
Fas, also known as CD95/APO-1/DR2, is a cell surface transmembrane 
death receptor from the tumor necrosis factor superfamily. Fas receptor ligation 
by FasL triggers a series of secondray messagaes inside the target cell wich 
mediates apoptosis [106, 107]. FasL is constitutively expressed on immune cells 
and triggers apoptosis of activated inflammatory cells, so FasL/Fas system plays 
an important role in the down-regulation of immune reactions [108]. During 
infection, the neutrophil life-span is extended, as exposure to bacterial LPS at the 
site of infection protects neutrophils from apoptosis [79, 109, 110]. Fas:FasL 
system has been shown to play a major role in neutrophil lifespan and clearance 
from the site of inflammation [108]. Most importantly, deregulation of Fas-
mediated neutrophil apoptosis correlates with incidence of autoimmune disorders 
[111-113]. Cosistent with the current knowledge [79, 109, 110] , we show that 
neutrophils cultured in the presence of LPS have a prolonged half life and display 
a decreased level of membrane Fas. This occurs in the absence of downregulation 
of Fas mRNA expression, thus suggesting that a post-transcriptional mechanism 
regulating Fas protein expression is likely active. Several evidence demonstrate 
that Fas is a true endogenous miR-23a target gene: i) upon LPS stimulation the 
increase in miR-23a expression is paralleled by a decrease in Fas membrane 
protein expression; ii) the recruitment of both Fas mRNA and miR-23a to the 
RISC complex is induced by LPS, iii) overexpression of miR-23a in primary 
neutrophils results into a decreased Fas antigen expression, thus mimicking the 
effect of LPS. A role of miR-23a as antiapoptotic miRNA has been previously 
described in osteoblast cell lines, in which miR-23a protects cells from apoptosis 
by decreasing the expression of membrane Fas [104]. 
Herein, it is important to highlight that these results we succesfully 
achieved thanks to the optimization of protocols that have never been applied to 
primary human neutrophils: the detection of RISC-associated miRNAs/mRNAs 
and overexpression of miRNA mimics. These technical achievements are of great 
value and open the way for future molecular studies in primary human 
neutrophils. 
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In conclusion, based on the results obtained in this study, we propose a 
novel molecular mechanism for  the pro-survival effect of LPS in neutrophils: 
LPS upregulates the expression of miR-23a, that in turn promotes the recruitment 
of Fas mRNA to the RISC complex where a translational silencing is achieved, 
leading to a reduced expression of the pro-apoptotic Fas antigen  (Figure 21). 
 
 
 
 
Figure 21. The proposed model for pro-survival effect of LPS on neutrophils 
via mir-23a/Fas. 
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Appendices 
 
Supplementary Table S1. Primers used in RT-qPCR analysis for pri-miRNAs. 
Target Sense Oligonucleotide Antisense oligonucleotide 
Pri-miR103a-2 TGTAGCATTCAGGTCAAGCAG ACACAGGGACAAGCCATAAG 
Pri-miR106b CTCCTTACCGTGCTCTCATTG CAACCACCCTCTCAGTGAAG 
Pri-miR1199 GCTGCGGGCTTTGAGAGTC TCGGGGCACGGCGGAAAAC 
Pri-miR1250 TCCCTGCCCCTGGTATGTC GCTCCTCACTGGTTGATGG 
Pri-miR1273h GACTAAGGCAGGATTGCTTG CCCACCCTCCAGAACCATG 
Pri-miR133a-1 CCAAATCGCCTCTTCAATGG GTTGTCCCGTAGTAATCAATGC 
Pri-miR142 GTTGGGGGGATCTTAGGAAG CAGTGCTGTTAGTAGTGCTTTC 
Pri-miR143 AGTTGGGAGTCTGAGATGAAG CAAGTGGCTGATAGTATGGAG 
Pri-miR145 TCCTCACGGTCCAGTTTTCC GACAGCCTTCTTCTTGAACC 
Pri-miR145 TCCTCACGGTCCAGTTTTCC GACAGCCTTCTTCTTGAACC 
Pri-miR146a CTGAAAAGCCGATGTGTATCC CAAGCCCACGATGACAGAG 
Pri-miR146b CGGGAGACGATTCACAGAAG CCTTGGCATTGATGTTGTAGC 
Pri-miR155 CAAACCAGGAAGGGGAAATC GCTAGTAACAGGCATCATACAC 
Pri-miR15a GCAGCACATAATGGTTTGTGG CCTTACTTCAGCAGCACAGTT 
Pri-miR17 CTGAAGATTGTGACCAGTCAG CCATAATGCTACAAGTGCCTTC 
Pri-miR181c GTTTGGGGGAACATTCAACC GCCTCAGGGTCCACTCAAC 
Pri-miR181D CACAGCCGAGGTCACAATC AGCCACAGTGACATTCATCC 
Pri-miR193a GCTGAGGGCTGGGTCTTTG CGAGAACTGGGACTTTGTAGG 
Pri-miR194-2 GAAGCCTCGGTGAAAAGACC CCTCGCCCCAGATAACAGC 
Pri-miR2117 AGGAACTGGAGAGAATGCTC CCTCAAGGCAATCAGATCAG 
Pri-miR22 GAGCCGCAGTAGTTCTTCAG CCAGATGATGGGGAAAGCAG 
Pri-miR221 CCCAGCATTTCTGACTGTTG AAACCCAGCAGACAATGTAGC 
Pri-miR222 CTGCTGGAAGGTGTAGGTAC GCTAGAAGATGCCATCAGAG 
Pri-miR223 ATCTCACTTCCCCACAGAAG GACAAACTGACACTCTACCAC 
Pri-miR23a-27a ACATTGCCAGGGATTTCCAAC GAACTTAGCCACTGTGAACAC 
Pri-miR24-2 CGCCTGTCTGCCTGCCATC CCCTGTTCCTGCTGAACTG 
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Pri-miR25 GTTGAGAGGCGGAGACTTG CTCACAAAACAGGAGTGGAATC 
Pri-miR29A CTAGCACCATCTGAAATCGG CCCCAACGGTCACCAATAC 
Pri-miR302b GCTCCCTTCAACTTTAACATGG GACACCTCCACTGAAACATGG 
Pri-miR3065 GCCCTCTTCAACAAAATCACTG GTCCTCTCCAACAATATCCTG 
Pri-miR3138 CTGTGGACAGTGAGGTAGAG GAAGATGCTGGGAAACTTCTG 
Pri-miR3153 CCTGAAGCACCGTACTAGAAC AAGTGTCCCGCATACAGTAAG 
Pri-miR3164 GCACACATCCACAGTAAGGC TGAGAGGTCCTGGGAAACTG 
Pri-miR3174 CGTTACCTGGTAGTGAGTTAG GTCCATCAGTGCTTTACAGAC 
Pri-miR3176 TGTGGGGCGTGTGTTAGAC CAGGGTGAAAGAGAAAGAGC 
Pri-miR3179-a TCTGTGATCCTGGGGTTGTTG GTAAGAAGGGCTGCTGTTTC 
Pri-miR3591 GCTCTGCTAAGGAAACTCTG GCTTGTACCCGTGATGCTTC 
Pri-miR3671 GTAAACACCAAGCCAGCATC CACTCCCGTGTGGGCAACA 
Pri-miR3682 CATAGCCCCCGTCCGTATC TACCTCCACCTGTATCATCATG 
Pri-miR373 CTTCCCCCATAGCAAGCAAG AAGCACTTCCCAGTACAGAC 
Pri-miR378D2 GGTTACAAGGAGAGAACACTG GGAACAGAAATGGGACTTAGAG 
Pri-miR3909 GACAGGGAAAAGCACACAAG CCTCCAGGACAGCACTTAG 
Pri-miR3945 CCCAGTACCCTAAAAGGAAC CTGTGGACCAGTCAGGAATC 
Pri-miR4257 GGGGACTGAGCCTTAGTTGG GGAGCAGGGAGGATCACTG 
Pri-miR4260 TGACACCCACCTTCAACAAG CACCAGAAACAGCCAGACATC 
Pri-miR4263 GCTCTTCAGGGTTTTACTTGG TGAGATCCACACTGCTTGTG 
Pri-miR4313 GTGGGGACACTGGGATCAG CTCCTGCTCGTCACATTCAC 
Pri-miR4313 GTGGGGACACTGGGATCAG CTCCTGCTCGTCACATTCAC 
Pri-miR4435 TACATCTCCTCAGAGTAAGGC CTTCCCTGATAGCATCTGTTG 
Pri-miR4441 TTGGAGCAGCAGTTTGTCAG TGCGGTTCTGTCTTGTTCTG 
Pri-miR4453 CTTGGTCTGTAGCGGTTTCC ATCAGGCTGTAGGGTAACTC 
Pri-miR4458 GTGTCTGTGTTACCAGTATGTG CCTCACTCATTTCTTCTCCAC 
Pri-miR4482 CTTCTCGTGGTGGTGATGTG CCCCTTCAAATCCTTCCTATC 
Pri-miR4635 GCAAAGTCCTGGTTTCTTCC CAGCGTGACAGTCTCTATCC 
Pri-miR4637 GTTAGGACCCTTACTTGGATC AGAACCCTCACTTGAATCTGC 
Pri-miR4645 AAGTTGCGACGAGACAGTAG ACTCCAGTAGTGACAAACCG 
Pri-miR4658 CCTTCACTCAGAGCATCTAC AGCGGTCATCACAAAACACG 
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Pri-miR4726 CAGCCTCCCCGCACTCTTC CACCCCTCCTCACTGTTGAC 
Pri-miR4742 ATCTGTATTCTCCTTTGCCTGC CCACTAGCGATGAAGTCTTC 
Pri-miR4772 CTCTATGGTCAGGTTGAGTC GGAAGACACAAGGGTATTGC 
Pri-miR4773-2 AAACGCTGTCTCAGAATCAGTG AGAAAGGCTGGGGAGCATC 
Pri-miR503 TCGTGGGGAAGGTAGAAGG GCCTAGCCAGGAATACTGC 
Pri-miR5187 CTGGATGGGGAAAAGACTAAG CACCTGAGGAAAAGAGGATTC 
Pri-miR5188 AGGTATGGAAAGGTCCTACTTG GGGTCCGATTATTGAATGGATC 
Pri-miR5684 CAGTTGTGGTGTGCTTGTAG GTTGCTCAGGCTAGAGTTCAG 
Pri-miR5685 GCAGCACAGTAGGCACTATG CCTTGTAATCACCTCTTGTTCC 
Pri-miR5696 AGTCTGATGCCTACTACTGATG CGCAGGAAGATGAGTCTATC 
Pri-miR570 GGTTTTGGGTGGAGAAAGAG CTGTGGATGTTATGCTGACTTC 
Pri-miR573 GCGGTTTCTCCCTGAAGTG ACTCTCCTCACCCTGACAAG 
Pri-miR579 TGGACAACCTCTAACCTTTCTG AATCGTCATCTGGCACAAACC 
Pri-miR589 TGCTCATAATGCCATCTCTGTG CCACCTGCTCCTTCCACTG 
Pri-miR600 GGAAGGGAAACTGACAAACTG CACTGCCTGACAGACAAGAG 
Pri-miR6075 TTGCTCCAGAGACACCACATG TTGGCACCAGTGTCGTCAC 
Pri-miR616 GTAATTCCTCCACTCAAAACCC GCAACTCTATTCACCATACAGC 
Pri-miR645 GCAGTCCAGTTCCTAACAGG CAGTCTCCAGGCTTCTCTG 
Pri-miR657 TGGGGAGCCGAGAGTGATAG GCCTAGAGAGGGTGAGAAC 
Pri-miR6738 CTAAATACCCTCCCAATCCAAG AACCCCTGTGCTCTTCTACC 
Pri-miR6749 GCTCTGTCCTGTCTCACTC GGTCACGCTGGTTGATGAG 
Pri-miR6750 GCTGTGTTAGCGAAGGGAAC GGAGCAGAGGGTGAGTTCT 
Pri-miR6766 TTCTCCTGCTCCTGATTGTC GCTCTGTGGTCCCCTTCAG 
Pri-miR6769A TGGTATGGAAGCCTGGTAAG CTCCTGGTTGTTCTTGTTCTC 
Pri-miR6772 CCACAGCCACATCAGTCATC CTTCTCCTTCAGGTGTTCTAC 
Pri-miR6775 GGCGGCTCAGGGTTTCCAG GGGGCTCAGGCGGCTTATG 
Pri-miR6807 GTGAGCCAGTGGAATGGAG CCAGCACAGCAGAGAACTTG 
Pri-miR6821 CCTTAGGCACCCGAGTGTAC GATGTCCCCACACACCATATC 
Pri-miR6895 CCAGGCACAGAGTAAGCATC TCCAGCAGCGTGTAGCAAG 
Pri-miR744 TAGGGCTAACAGCAGTCTTAC TGGCACGACACAATAAGGAC 
Pri-miR7976 CTCAGGGCAGATTTTCATTGG TGGTAAGAGCACCGTTTTCC 
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Pri-miR93 TGTGCTACAGACCTTCCTTTC AGACCAGACCCTTTTGAACG 
Pri-miR940 TTCAAGCCGAAGCATCCAAC GCCTTCCTTCCTCAACACAC 
Pri-miRLet7b GTAGGTTGTGTGGTTTCAGG CAGGGAAGGCAGTAGGTTG 
Pri-miRLet7i TGGCTGAGGTAGTAGTTTGTG AGCACTAGCAAGGCAGTAGG 
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Supplementary Table S2. List of miRNA genes detected in freshly isolated 
neutrophils and/or monocytes.  
 
PMN Mono 
  
PMN Mono 
  
PMN Mono 
MIR3180-3 0.0069 0.0000 
 
MIR4322 0.0707 0.0000 
 
MIR548AT 0.2580 0.0000 
MIR4523 0.0129 0.0000 
 
MIR553 0.0721 0.0000 
 
MIR7155 0.2719 0.0000 
MIR1284 0.0408 0.0000 
 
MIR181D 0.0754 0.0000 
 
MIR140 0.2792 0.0000 
MIR766 0.0438 0.0000 
 
MIR6806 0.0766 0.0000 
 
MIR5700 0.2798 0.0000 
MIR582 0.0438 0.0000 
 
MIR4692 0.0778 0.0000 
 
MIR491 0.2816 0.0000 
MIR92B 0.0450 0.0000 
 
MIR4459 0.0782 0.0000 
 
MIR1227 0.2904 0.0000 
MIR148B 0.0450 0.0000 
 
MIR6846 0.0817 0.0000 
 
MIR4285 0.2945 0.0000 
MIR30E 0.0457 0.0000 
 
MIR4726 0.0845 0.0000 
 
MIR548H1 0.3011 0.0000 
MIR365B 0.0465 0.0000 
 
MIR6833 0.0846 0.0000 
 
MIR4646 0.3236 0.0000 
MIR181C 0.0469 0.0000 
 
MIR6504 0.0846 0.0000 
 
MIR6815 0.3257 0.0000 
MIR504 0.0474 0.0000 
 
MIR548AK 0.0860 0.0000 
 
MIR5696 0.3552 0.0000 
MIR624 0.0505 0.0000 
 
MIR340 0.0883 0.0000 
 
MIR33A 0.3628 0.0000 
MIR617 0.0505 0.0000 
 
MIR6131 0.0899 0.0000 
 
MIR4773-2 0.4599 0.0000 
MIR607 0.0511 0.0000 
 
MIR450A2 0.0930 0.0000 
 
MIR3939 0.4821 0.0000 
MIR132 0.0511 0.0000 
 
MIR1976 0.0993 0.0000 
 
MIR6867 0.5199 0.0000 
MIR141 0.0516 0.0000 
 
MIR6826 0.1027 0.0000 
 
MIR101-1 0.5987 0.0000 
MIR548Q 0.0516 0.0000 
 
MIR576 0.1027 0.0000 
 
MIR6812 0.8588 0.0000 
MIR602 0.0527 0.0000 
 
MIR6075 0.1032 0.0000 
 
MIR548E 0.9825 0.0000 
MIR3688-1 0.0527 0.0000 
 
MIR629 0.1038 0.0000 
 
MIR3065 2.2566 0.0000 
MIR595 0.0538 0.0000 
 
MIR320C1 0.1144 0.0000 
 
MIR5685 4.8998 0.0000 
MIR326 0.0543 0.0000 
 
MIR3135A 0.1307 0.0000 
 
MIR137HG 0.0021 0.0031 
MIR558 0.0549 0.0000 
 
MIR190B 0.1313 0.0000 
 
MIR7515HG 0.0029 0.0016 
MIR5192 0.0561 0.0000 
 
MIR4667 0.1336 0.0000 
 
MIR3180-1 0.0067 0.0288 
MIR4296 0.0587 0.0000 
 
MIR6876 0.1379 0.0000 
 
MIR497HG 0.0079 0.0071 
MIR938 0.0591 0.0000 
 
MIR302B 0.1379 0.0000 
 
MIR490 0.0088 0.0118 
MIR4511 0.0593 0.0000 
 
MIR4480 0.1381 0.0000 
 
MIR181A1HG 0.0124 0.2841 
MIR548L 0.0600 0.0000 
 
MIR941-3 0.1398 0.0000 
 
MIR3654 0.0124 0.0441 
MIR4802 0.0613 0.0000 
 
MIR4533 0.1418 0.0000 
 
MIR3180-4 0.0143 0.1672 
MIR548P 0.0615 0.0000 
 
MIR6737 0.1438 0.0000 
 
MIR133A1HG 0.0169 0.0045 
MIR4753 0.0622 0.0000 
 
MIR6852 0.1525 0.0000 
 
MIR205HG 0.0186 0.0061 
MIR15A 0.0622 0.0000 
 
MIR6089 0.1532 0.0000 
 
MIR3911 0.0201 0.1436 
MIR8087 0.0628 0.0000 
 
MIR5091 0.1581 0.0000 
 
MIR503HG 0.0209 0.1801 
MIR4783 0.0630 0.0000 
 
MIR604 0.1648 0.0000 
 
MIR600HG 0.0243 0.0381 
MIR4284 0.0637 0.0000 
 
MIR548AY 0.1857 0.0000 
 
MIR4454 0.0251 0.0096 
MIR4294 0.0645 0.0000 
 
MIR3609 0.1871 0.0000 
 
MIR3179-1 0.0294 0.0769 
MIR1200 0.0645 0.0000 
 
MIR378E 0.1894 0.0000 
 
MIR7851 0.0323 0.1290 
MIR7974 0.0653 0.0000 
 
MIR4433A 0.1948 0.0000 
 
MIR4500HG 0.0325 0.0131 
MIR5693 0.0672 0.0000 
 
MIR4718 0.2024 0.0000 
 
MIR99AHG 0.0337 0.0202 
MIR4752 0.0681 0.0000 
 
MIR548C 0.2075 0.0000 
 
MIR3615 0.0365 0.0669 
MIR3165 0.0688 0.0000 
 
MIR99B 0.2212 0.0000 
 
MIR335 0.0398 0.0235 
MIR6853 0.0698 0.0000 
 
MIRLET7G 0.2255 0.0000 
 
MIR17HG 0.0418 0.1715 
MIR4699 0.0698 0.0000 
 
MIR548AC 0.2287 0.0000 
 
MIR191 0.0434 0.0506 
MIR3159 0.0698 0.0000 
 
MIR6803 0.2303 0.0000 
 
MIR1255A 0.0434 0.0506 
MIR4689 0.0700 0.0000 
 
MIR4673 0.2537 0.0000 
 
MIR1301 0.0438 0.0444 
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PMN Mono 
  
PMN Mono 
  
PMN Mono 
MIR3657 0.0441 0.1829 
 
MIR342 0.1017 0.1080 
 
MIR378J 0.2770 0.8057 
MIR7-3HG 0.0445 0.0190 
 
MIR3179-3 0.1027 0.0550 
 
MIR6719 0.2847 0.3775 
MIRLET7I 0.0454 0.2580 
 
MIR7845 0.1043 0.5829 
 
MIR941-1 0.2868 0.0691 
MIR146A 0.0456 0.0690 
 
MIR4754 0.1102 0.1202 
 
MIR6855 0.2965 0.1708 
MIR331 0.0465 0.0516 
 
MIR2117 0.1102 0.2016 
 
MIR6858 0.3082 0.4566 
MIR212 0.0469 0.0520 
 
MIR4644 0.1167 0.0592 
 
MIR3153 0.3084 0.0607 
MIR210HG 0.0477 0.0805 
 
MIR6077 0.1196 0.0698 
 
MIR6842 0.3097 0.2296 
MIR4782 0.0478 0.0921 
 
MIR1238 0.1213 0.0689 
 
MIR6781 0.3104 0.0894 
MIR579 0.0500 0.0508 
 
MIR1285-1 0.1229 0.2458 
 
MIR8075 0.3129 0.0622 
MIR4440 0.0500 0.1168 
 
MIR499A 0.1248 0.0469 
 
MIR3127 0.3185 0.4370 
MIR550A1 0.0505 0.0513 
 
MIR3192 0.1360 0.1466 
 
MIR7107 0.3194 0.8551 
MIR151B 0.0511 0.1710 
 
MIR219A1 0.1361 0.3301 
 
MIR3936 0.3238 0.1493 
MIR143HG 0.0522 0.0269 
 
MIR3181 0.1379 0.0681 
 
MIR548AR 0.3440 2.4350 
MIR145 0.0536 0.0274 
 
MIR6752 0.1418 0.3013 
 
MIR371B 0.3506 0.2365 
MIR4999 0.0539 0.0629 
 
MIR6810 0.1438 0.6326 
 
MIR4668 0.3539 0.1528 
MIR6728 0.0551 0.1202 
 
MIR6851 0.1463 0.1485 
 
MIR194-2 0.3543 0.0458 
MIR4258 0.0567 0.1175 
 
MIR6885 0.1525 0.0867 
 
MIR1254-1 0.3618 1.6310 
MIR1273D 0.0570 0.0665 
 
MIR6754 0.1525 0.1507 
 
MIR302A 0.3665 0.2163 
MIR6124 0.0577 0.0673 
 
MIR3128 0.1525 0.3015 
 
MIR8086 0.3746 0.1150 
MIR378H 0.0591 0.0689 
 
MIR1827 0.1588 0.0880 
 
MIR3198-1 0.3774 0.0715 
MIR4737 0.0605 0.9336 
 
MIR769 0.1684 0.0970 
 
MIR6729 0.3891 0.2296 
MIR1255B1 0.0610 0.0540 
 
MIR1537 0.1693 0.0815 
 
MIR6738 0.3911 0.6802 
MIR3146 0.0621 0.4252 
 
MIR6808 0.1750 0.0843 
 
MIR6793 0.3973 0.1817 
MIR1290 0.0628 0.0638 
 
MIR425 0.1750 0.0658 
 
MIR940 0.4003 0.6026 
MIR4766 0.0645 0.0753 
 
MIR4727 0.1783 0.2985 
 
MIR568 0.4183 0.3012 
MIR4469 0.0653 0.0630 
 
MIR328 0.1790 0.0964 
 
MIR647 0.4248 2.3243 
MIR4767 0.0662 0.6665 
 
MIR222 0.1797 0.0444 
 
MIR302C 0.4440 0.2926 
MIR3591 0.0670 0.0237 
 
MIR374B 0.1797 0.2865 
 
MIR302D 0.4478 0.0732 
MIR6797 0.0681 0.2177 
 
MIR3178 0.1813 0.1363 
 
MIR6838 0.4516 0.1910 
MIR4734 0.0700 0.0711 
 
MIR4786 0.1838 0.0622 
 
MIR548AA1 0.4602 0.6027 
MIR941-4 0.0717 0.1486 
 
MIR4451 0.1888 0.2050 
 
MIR4730 0.4618 0.1964 
MIR941-2 0.0717 0.2280 
 
MIR1199 0.1934 0.0986 
 
MIR5194 0.4624 0.0829 
MIR7111 0.0717 2.5152 
 
MIR3161 0.1977 0.0646 
 
MIR3926-1 0.4808 0.0784 
MIR155HG 0.0721 0.0554 
 
MIR641 0.2007 0.2085 
 
MIR4263 0.4850 1.0310 
MIR4442 0.0732 0.4159 
 
MIR4259 0.2019 0.0492 
 
MIR4313 0.5013 0.0302 
MIR1229 0.0748 0.2992 
 
MIR4534 0.2186 0.1428 
 
MIR601 0.5063 0.2613 
MIR367 0.0759 0.0842 
 
MIR1249 0.2235 1.4770 
 
MIR4685 0.5124 0.2380 
MIR3677 0.0817 0.4395 
 
MIR6804 0.2239 0.6914 
 
MIR5187 0.5229 1.3814 
MIR8072 0.0828 0.2221 
 
MIR1273A 0.2481 0.2004 
 
MIR548O 0.5297 0.2247 
MIR4669 0.0833 0.1605 
 
MIR6736 0.2537 0.2656 
 
MIR4530 0.5345 2.7182 
MIR6515 0.0860 0.2008 
 
MIR5581 0.2538 0.3441 
 
MIR4688 0.5472 0.0599 
MIR202HG 0.0867 0.0572 
 
MIR6895 0.2547 0.0734 
 
MIR3189 0.5550 0.1465 
MIR6740 0.0868 0.2774 
 
MIR877 0.2649 0.0938 
 
MIR3174 0.5874 0.4432 
MIR27B 0.0908 0.1060 
 
MIR421 0.2673 0.1910 
 
MIR4674HG 0.6110 0.6932 
MIR181B1 0.0939 0.3121 
 
MIR519A2 0.2736 0.2167 
 
MIR1302-9 0.6196 1.4324 
MIR1539 0.0944 0.1667 
 
MIR4324 0.2759 0.2177 
 
MIR623 0.6215 0.3198 
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  PMN Mono 
  
PMN Mono 
  
PMN Mono 
MIR4477B 0.6245 3.1020 
 
MIR645 1.4085 0.2196 
 
MIR25 7.8617 1.9783 
MIR6779 0.6250 0.4003 
 
MIR6723 1.4415 60.9185 
 
MIR635 8.2184 4.4779 
MIRLET7BHG 0.6544 0.2506 
 
MIR4482 1.4452 1.6029 
 
MIR616 8.5348 10.1431 
MIR6818 0.6551 0.2524 
 
MIR765 1.4578 1.5449 
 
MIR103A2 9.4058 2.7078 
MIR6892 0.6666 0.6339 
 
MIR4441 1.5149 0.3706 
 
MIR6891 10.7981 12.5049 
MIR3173 0.6679 0.2195 
 
MIR4435-1 1.5481 0.7625 
 
MIR6753 11.2449 5.1511 
MIR3138 0.6703 0.2609 
 
MIR573 1.5770 1.0502 
 
MIR4489 12.5203 2.0100 
MIR2355 0.6941 0.0572 
 
MIR4312 1.5823 0.6087 
 
MIR3916 13.2495 20.0386 
MIR6832 0.6953 0.5943 
 
MIR744 1.5985 0.0584 
 
MIR142 16.4481 14.0816 
MIR646HG 0.6960 0.2313 
 
MIR4260 1.6064 0.3305 
 
MIR4772 17.6743 0.0734 
MIR6509 0.7165 0.8136 
 
MIR6080 1.6122 1.1675 
 
MIR4257 27.0833 6.5200 
MIR26A2 0.7251 0.1184 
 
MIR6807 1.6409 0.9761 
 
MIR6749 27.5500 1.1790 
MIR4292 0.7394 4.9676 
 
MIR4648 1.6665 7.6460 
 
MIR4420 36.6021 35.6141 
MIR6822 0.7531 0.1876 
 
MIR570 1.7665 3.0773 
 
MIR23A 40.6472 53.1642 
MIR4645 0.7639 1.0725 
 
MIR6894 1.7794 0.8773 
 
MIR24-2 40.6585 67.9095 
MIR6802 0.7702 0.4057 
 
MIR589 1.8535 0.8871 
 
MIR6750 49.0498 2.6071 
MIR4453 0.7988 0.2653 
 
MIR221 1.8768 2.9717 
 
MIR27A 53.8689 73.1656 
MIRLET7A1 0.8162 0.1163 
 
MIR3682 1.9139 0.3317 
 
MIR22HG 57.3325 34.7720 
MIR33B 0.8333 0.2747 
 
MIR186 1.9804 2.4789 
 
MIR223 76.5551 23.5203 
MIR5684 0.8496 2.1813 
 
MIR3945 2.0013 0.6041 
 
MIR4697HG 0.0000 0.0019 
MIR644A 0.9581 0.1058 
 
MIR320E 2.0253 0.2421 
 
MIR663AHG 0.0000 0.0022 
MIR135A1 0.9606 0.6329 
 
MIR6769A 2.0716 0.5180 
 
MIR451A 0.0000 0.0064 
MIR6746 0.9750 0.5212 
 
MIR7152 2.1506 2.4692 
 
MIR31HG 0.0000 0.0077 
MIR199A1 0.9959 0.4414 
 
MIR6848 2.3116 1.2332 
 
MIR4458HG 0.0000 0.0378 
MIR1273H 1.0034 0.2637 
 
MIR29B1 2.3601 0.3070 
 
MIR4461 0.0000 0.0385 
MIR3164 1.0291 1.3667 
 
MIR3690 2.3640 0.5705 
 
MIR5572 0.0000 0.0418 
MIR4326 1.0323 1.2228 
 
MIR4298 2.5030 0.1363 
 
MIR3149 0.0000 0.0444 
MIR3613 1.0501 0.3031 
 
MIR6777 2.8309 0.4862 
 
MIR378D2 0.0000 0.0451 
MIR29A 1.0563 0.1996 
 
MIR6865 3.0533 0.2526 
 
MIR1256 0.0000 0.0481 
MIR628 1.0713 0.6485 
 
MIR6813 3.1381 1.1194 
 
MIR4305 0.0000 0.0488 
MIR6514 1.0802 1.5992 
 
MIR4742 3.2607 1.1823 
 
MIR5006 0.0000 0.0520 
MIR6864 1.0839 1.2439 
 
MIR4639 3.4334 1.3340 
 
MIR1262 0.0000 0.0535 
MIR26B 1.1050 4.5684 
 
MIRLET7D 3.5622 4.3407 
 
MIR7849 0.0000 0.0540 
MIR4513 1.1072 0.8446 
 
MIR4658 3.6366 1.5461 
 
MIR3680-2 0.0000 0.0572 
MIR7847 1.1376 0.3816 
 
MIR590 3.7218 4.4932 
 
MIR619 0.0000 0.0578 
MIR4632 1.1635 0.5261 
 
MIR3909 4.0512 1.8899 
 
MIR345 0.0000 0.0584 
MIR5010 1.1698 1.5631 
 
MIR6069 4.4627 1.6499 
 
MIR5089 0.0000 0.0592 
MIR6775 1.1707 1.3991 
 
MIR657 4.5984 0.3351 
 
MIR4779 0.0000 0.0599 
MIR4690 1.1915 1.1651 
 
MIR3671 4.9558 0.5427 
 
MIR3162 0.0000 0.0607 
MIR3136 1.2308 0.3380 
 
MIR1250 5.8695 0.2707 
 
MIR3202-1 0.0000 0.0614 
MIR4426 1.2493 14.1109 
 
MIR106B 6.0109 0.7129 
 
MIR7850 0.0000 0.0630 
MIR373 1.3127 1.5069 
 
MIR6819 6.1515 2.1490 
 
MIR5088 0.0000 0.0630 
MIR6766 1.3297 1.6550 
 
MIR324 6.3224 12.0582 
 
MIR544B 0.0000 0.0638 
MIR6763 1.3301 0.5932 
 
MIR7848 7.0883 1.8867 
 
MIR4516 0.0000 0.0665 
MIRLET7F1 1.3326 0.7779 
 
MIR93 7.1063 0.5442 
 
MIR28 0.0000 0.0665 
MIR6835 1.3509 1.7649 
 
MIR6821 7.3513 5.5096 
 
MIR4771-2 0.0000 0.0672 
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  PMN Mono 
  
PMN Mono 
MIR4787 0.0000 0.0681 
 
MIR4519 0.0000 0.1605 
MIR3922 0.0000 0.0681 
 
MIR6893 0.0000 0.1659 
MIR4671 0.0000 0.0681 
 
MIR661 0.0000 0.1677 
MIR4653 0.0000 0.0689 
 
MIR6776 0.0000 0.1686 
MIR429 0.0000 0.0689 
 
MIR6784 0.0000 0.1708 
MIR3158-1 0.0000 0.0706 
 
MIR4642 0.0000 0.1820 
MIR6799 0.0000 0.0721 
 
MIR339 0.0000 0.1860 
MIR6757 0.0000 0.0721 
 
MIR6747 0.0000 0.1876 
MIR4323 0.0000 0.0721 
 
MIR937 0.0000 0.1909 
MIR6801 0.0000 0.0724 
 
MIR3186 0.0000 0.1932 
MIR7975 0.0000 0.0732 
 
MIR193A 0.0000 0.1951 
MIR5692C2 0.0000 0.0743 
 
MIR4660 0.0000 0.2017 
MIR4757 0.0000 0.0743 
 
MIR6512 0.0000 0.2035 
MIR4512 0.0000 0.0743 
 
MIR6761 0.0000 0.2073 
MIR8061 0.0000 0.0763 
 
MIR4635 0.0000 0.2078 
MIR3118-2 0.0000 0.0784 
 
MIR4444-1 0.0000 0.2118 
MIR6731 0.0000 0.0795 
 
MIR378I 0.0000 0.2160 
MIR4681 0.0000 0.0795 
 
MIR378A 0.0000 0.2287 
MIR4316 0.0000 0.0806 
 
MIR6816 0.0000 0.2374 
MIR32 0.0000 0.0818 
 
MIR4677 0.0000 0.2674 
MIR98 0.0000 0.0836 
 
MIR3942 0.0000 0.2807 
MIR6856 0.0000 0.0854 
 
MIR4505 0.0000 0.2828 
MIR4641 0.0000 0.0867 
 
MIR3155B 0.0000 0.3216 
MIR4449 0.0000 0.0867 
 
MIR6825 0.0000 0.3241 
MIR7856 0.0000 0.0888 
 
MIR3176 0.0000 0.3649 
MIR215 0.0000 0.0904 
 
MIR4425 0.0000 0.3731 
MIR6880 0.0000 0.0923 
 
MIR621 0.0000 0.5131 
MIR200B 0.0000 0.0964 
 
MIR4664 0.0000 0.5220 
MIR486-1 0.0000 0.1022 
 
MIR3685 0.0000 0.5978 
MIR361 0.0000 0.1022 
 
MIR6739 0.0000 0.6568 
MIR659 0.0000 0.1103 
 
MIR593 0.0000 0.7985 
MIR8064 0.0000 0.1105 
 
MIR5587 0.0000 0.8214 
MIR574 0.0000 0.1192 
 
MIR4740 0.0000 0.9635 
MIR6762 0.0000 0.1244 
 
MIR4722 0.0000 1.8782 
MIR5094 0.0000 0.1258 
 
MIR6503 0.0000 2.8260 
MIR153-1 0.0000 0.1272 
 
MIR6774 0.0000 4.0228 
MIR5092 0.0000 0.1301 
    
MIR3188 0.0000 0.1346 
    
MIR4537 0.0000 0.1421 
    
MIR5195 0.0000 0.1428 
    
MIR185 0.0000 0.1438 
    
MIR5188 0.0000 0.1453 
    
MIR3940 0.0000 0.1463 
    
MIR3944 0.0000 0.1520 
    
MIR6829 0.0000 0.1597 
    
 Data obtained from RNA-sequencing are shown as FPKM related to each miRNA gene. 
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Supplementary Table S3. List of immune related genes targeted by the 
members of miR23a-5p and miR27a-5p. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
miRNA Potential immune related target genes 
miR23a-5p IRF1, COLQ, COL11A2, PTK2B, BNI3BL, FAS 
miR27a-5p 
IRF4, ZFHX4, DLL4 ,GRB2, NGFR, NRP2, CSF1, NPTX2, RUNX1, 
CADM1, ARHGEF7, CNTNAP2, NLK, MAP3K12, STRBP, 
TMEM25, BNIP3L, MAPK14 
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Supplementary Figure S1. LPS stimulation modulates pri-miRNA expression 
in monocytes.  
Hierarchical Clustering Analysis of pri-miRNA expression in monocytes freshly purified 
or cultured for 90 min and 4h in the presence of LPS. The expression levels of LPS-
modulated pri-miRNAs (|Log2FC|>1, Pval<0.05) in monocytes are shown as 
Log10(FPKM+1), centered to the mean across the genes in row. 
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